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The biological and photochemical properties associated with psoralens and isopsoralens have 
resulted in this class of compounds being widely investigated. Much emphasis has been placed 
on the synthesis of different analogues of these compounds as a means to fine tune these 
properties and therefore enhance their value to the medical community. Synthetic approaches 
carried out have concentrated on the preparation of various substituted derivatives, as well as the 
synthesis of heteroanalogues of these compounds, where one or both of the intracyclic oxygen 
atoms have been replaced with sulfur, nitrogen and even in some cases, selenium. 
In this project, the synthesis of a number of alkyl substituted isopsoralen analogues were 
investigated, utilising the reductive ozonolysis of o-allyl hydroxycoumarins as a key synthetic 
step. This approach led to the preparation of a number of novel 8-alkyl substituted 8,9-dihydro-
2//-furo[2,3-/i]chromen-2-ones in good yields. 
This approach was subsequently extended in order to achieved the synthesis of sulfur analogues 
of isopsoralen, with the sulfur atom replacing the oxygen atom of the furan ring. Conversion of 
the hydroxy group of the o-allyl hydroxycoumarin into the protected thiol, followed by reductive 
ozonolysis and deprotection of the thiol, afforded 8-methoxy-8,9-dihydro-2//-thieno[2,3-/z] 
chromen-2-one. 
Preliminary investigations into the inclusion of selenium into the benzofuran ring system have 
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1. INTRODUCTION 
1.1 BACKGROUND 
The family of furocoumarin derivatives, known as psoralens, belong to an important class of 
natural and synthetic heterocyclic compounds which have been widely utilised both as drugs for 
the photo chemotherapeutic treatment of a range of topical skin diseases, as well as useful probes 
for the DNA and RNA structure and function of viral, bacterial and mammalian systems.1'2'3 
Structurally, psoralens are tricyclic ring systems formed by the fusion of a furan ring with a 
coumarin. A linear fusion of these two structures affords a psoralen, while an angular fusion 
leads to an isopsoralen, also known as angelicin. Figure 1 shows the structure of psoralen, 
angelicin, and some psoralen derivatives, as well as the numbering system typically used for 
these types of compounds. Both psoralens and isopsoralens have been isolated and characterised 










1.1.1 Uses of Psoralens 
Clinically, psoralen derivatives are used in PUVA (psoralen plus UV-A) therapy and as such are 
used to treat a variety of topical skin diseases such as psoriasis and vitiligo.3'6 More recently, 
psoralens have also found use in extracorporeal photochemotherapy as a treatment of cutaneous 
T-cell lymphomas and other autoimmune diseases,7 and they are also now recognised as effective 
virucidal agents, especially against enveloped viruses such as the herpes simplex virus and the 
human immunodefiency virus type 1 (HIV-1 ).8 Psoralens have also proved to be a useful tool for 
the elucidation of the structure and function of nucleic acid in living systems,1 as well as useful 
model compounds for mutagenesis and repair studies.9 
1.2 INTERACTION WITH DNA 
The biological activity of psoralens is essentially due to the photochemical reaction that occurs 
between psoralens and nucleic acids, especially DNA.1 The primary site of this photo reaction is 
Thymine,10 apyrimidine base found in DNA, and the process follows three distinct steps. The first 
step involves intercalation of the planar psoralen between the base pairs of a DNA double helix 
(Figure 2). 
1.08nm 
Figure 2: A schematic representation of the intercalation of 8-MOP between the base pairs of 
a DNA double helix. 
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In Figure 2, the intercalation of 8-MOP is clearly visible. It can be seen that the planar psoralen 
is optimally sized to fit into the geometric constraints11 provided by the positioning of the bases. 
The structures of the bases have been simplified in order to provide a clearer and more concise 
representation of the intercalation step. 
The subsequent step involves absorption of a long wave UV light photon (320-410 nm), inducing 
the intercalated psoralen to undergo a [2,2] cycloaddition reaction with the adjacent pyrimidine 
base. This reaction takes place between the 3,4 or 4',5' double bonds of the psoralen and the 5,6 
double bond of the pyrimidine base to form either a furan-side or a pyrone-side monoadduct. 
Looking at Figure 2, the bases displayed in green are those with which cycloaddition can occur. 
Absorption of a second photon by some properly positioned monoadducts can then lead to the 
formation of a diadduct, resulting in interstrand cross-linking of the DNA double helix (Scheme 
1). These adducts interfere with the unwinding of the DNA helix during replication, thus 
preventing replication and leading to the subsequent death of the cell. 
Scheme 1: The formation and structures of (A) the pyrone-side 8-MOP-pyrimidine monoadduct 
and (B), the 8-MOP-pyrimidine diadduct. 
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There has been extensive investigation of the photochemical addition products that are formed 
between psoralens and the pyrimidine bases of DN A and RN A, with the detailed structure of both 
monoadducts and diadducts formed with several psoralen derivatives having been reported.2121314 
Studies have also been conducted on sequence specificity10 and thermal properties15 of selected 
psoralen crosslinks, and the excited states of some psoralen derivatives have also been studied 
using luminescence and photoselection measurements.16 Recent research in Italy has resulted in 
the development of a computational molecular modelling tool of DNA-psoralen complexes in 
order to help in the design of new furocoumarins.17 
The versatility of psoralen chemistry arises from the degree of control that can be achieved 
within the reaction, by controlled timing of the delivery of the light. Furthermore, the 
monoadducts and diadducts (crosslinks) formed between psoralens and pyrimidines can be 
reversed with short wavelength ultraviolet light, a property used to great advantage in the 
determination of nucleic acid secondary structure using psoralens.1 
1.2.1 Bifunctionality versus Monofuctionality 
In spite of the success of the traditionally used psoralen derivatives 8-MOP and TMP in PUVA 
therapy, there have been a number of undesirable side effects associated with such treatment,3 
including skin phototoxicity, mutation and skin carcinogenesis. These side effects are generally 
attributed largely to the formation of interstrand crosslinks in the DNA double helix. As a result 
of protracted debates in the clinical community over the relative mutagenicity and/or 
carcinogenicity of monoadducts versus crosslinks, there has been increased interest in the 
synthesis of monofunctional psoralen derivatives which only add once to DNA, in the hope of 
overcoming the side effects experienced in traditional PUVA therapy.3 
Isopsoralens, due to their angular geometry, do not crosslink to DNA. Their geometry is such that 
once a monoadduct has been formed, further reaction with a pyrimidine residue on the adjacent 
nucleic acid strand to form a crosslink is not possible due to a misalignment of the two reactive 
double bonds. There has thus been extensive interest in the synthesis of various isopsoralen 
derivatives in order to determine the extent of their reactivity towards DNA as an application in 
photochemotherapy, in comparison to the traditionally used 8-MOP and TMP. In fact, several 
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methylangelicin derivatives such as 6,4'-dimethyl and 4,6,4'-trimethylangelicin have been shown 
to have a much lower mutagenic activity and genotoxicity than 8-MOP. While they lacked any 
skin erythemogenic activity, they still showed a high antiproliferative activity; proving to be more 
effective than 8-MOP in the clearing of psoriatic lesions.18 
Another way of blocking the bifunctionality of psoralens is to introduce steric hindrance or 
electron-withdrawing groups into the active sites. This type of research has led to the preparation 
and photobiological testing of derivatives such as pyridopsoralens19 and carbethoxypsoralens.20 
Certain pyrrolocoumarins have also been found to be monofunctional and thus lacking in any 
skin phototoxicity.21 
1.2.2 Effects of Substituents 
The ability of the psoralen ring sytem to intercalate into and photobind to DNA and RNA is 
greatly influenced by the steric, position and electronic characteristics of the different substituents 
that are present on the parent compound. There have been many correlations made towards the 
extent of the effects that different substituents have on the photochemistry of psoralen 
derivatives. Some of the general trends known are the following: 
(i) The photochemical effects of methylated psoralens and isopsoralens are much quicker than 
the unsubstituted analogues, with 6-methylangelicins showing an extremely high 
antiproliferative activity;18 
(ii) Methyl substitution also seems to have an effect on pyrone versus furan photoaddition. Thus 
8- MOP, with a methyl in the 4-position shows an overwhelming preference for addition 
to the furan double bond (ca. 98 %), attributed to steric interference between this methyl 
group and the 5-methyl group of thymine in the DNA. Those without this group show 
a much higher proportion of pyrone double bond addition (ca. 18 %);22 
(iii) A methoxy group at the 8-position slows the photochemistry, for example, 8-MOP reacts 
much more slowly with DNA and also has a much greater half-life in solution than 
TMP;23 and 
(iv) Other strong electron withdrawing or donating groups such as hydroxy, amino, and nitro 
groups either drastically reduce or completely eliminate the ability of the psoralen to 
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undergo photocycloaddition with nucleic acids. For example, 8-MOP substituted at the 
5- position with an amino or nitro group shows no reactivity with DNA.23 
1.3 SYNTHETIC ROUTES TOWARDS PSORALEN DERIVATIVES 
The synthetic strategies which have been developed largely involve the preparation of the 
psoralen tricyclic ring system from either a coumarin or a benzofuran and subsequently extending 
the synthetic procedure to the third ring (i.e. the furan or pyrone ring) respectively. These two 
systems were originally prepared from resorcinol or a derivative (Scheme 2), in this case the 
substituents at the 5 and 8 positions of the final psoralen were those present in the resorcinol 
derivative used in the initial step. 
Less utilised methods involve the exocyclic modification of the intact psoralen nucleus. Some 
recent approaches involve the use of a single ring system other than resorcinol from which to 
build on the furan and pyrone rings using various synthetic procedures. All these techniques are 
able to lead to a large range of psoralen derivatives containing many different functionalities. 
or 
1.3.1 General Psoralen Synthesis 
Scheme 2 
1.3.1.1 Using o-allyl-7-hydroxycoumarins 
One of the more common methods utilised for psoralen synthesis involves the use of o-allyl 
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hydroxy coumarins as a starting material, with attention being directed towards the synthesis of 
the furan ring in order to complete the system. Kaufman24 reported the synthesis of methyl-
substituted psoralens and isopsoralens via this starting material using a method involving Claisen 





(i)220°C; (ii) Ac20, NaOAc; (iii)Br2; (iv) KOH, C2H5OH 
Scheme 3 
(i) 220°C; (ii) Ac20, NaOAc; (iii) Br2; (iv) KOH, C2H5OH 
Scheme 4 
Kaufman utilised this method in later work for the synthesis of 8-amino-4,5'-dimethyl psoralen,25 
where 4-methylcoumarin was nitrated to give an amino group in the 8-position. Acetylation, 
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bromination and cyclisation as previously achieved then afforded the desired psoralen. This 
method was a novel approach towards these types of derivatives at the time. Previous methods 
had mostly consisted of the preparation of these types of compounds from o-formyl or o-acyl-7-
hydroxycoumarins in three or four steps. However, the former compounds were generally 
prepared in low yield, while the latter coumarins were produced by Fries rearrangements, which 
frequently led to mixtures of isomeric compounds. The work reported by Kaufman was thus one 
of the first to demonstrate the value of o-allyl-hydroxycoumarins as intermediates in the synthesis 
of furocoumarin derivatives. 
Research reported by Roy and Sen26 describe the use of 6-allyl-5-hydroxycoumarin, as well as 
6-acetyl-5-hydroxycoumarin in the preparation of two, methyl-substituted allopsoralens (4a,b). 
6-AUyl-5-hydroxycoumarin (2), on cyclisation with hydrobromic acid in glacial acetic acid gave 
2,3-dihydro-2-methyl allopsoralen (3). This subsequently led to the isopsoralen derivative 4a on 
dehydrogenation over Pd/C in boiling diphenyl oxide (Scheme 5). The synthesis of the 
isopsoralen derivative 4b was achieved via condensation of 6-acetyl-5-hydroxycoumarin with 
ethyl bromoacetate to yield 5, the corresponding acid of which gave the psoralen derivative 4b 
on heating with acetic anhydride and sodium acetate (Scheme 5). 
H3C 
(5) 4a: R{= CH3, R2= H 
4b: Rj= H, R2= CH3 
(i) Dimethylaniline, reflux; (ii) HBr/ CH3COOH, reflux; 
(iii) Diphenyl oxide, 10% Pd/C; (iv) Acetic anhydride, sodium acetate 
Scheme 5 
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6-Allyl-7-hydroxycoumarins have also been applied to the synthesis of a range of 8-acetyl-
psoralens.27 The introduction of the acetyl into the 8-position was achieved via a Fries 
rearrangement28 of the acetate of coumarin 6 to produce 7 (Scheme 6). The corresponding allyl 
ethers were obtained by reaction with either allyl bromide or 2,3-dichloro-1 -propene in 1:1 DMF 
and benzene mixture together with potassium carbonate at 80°C to yield the allylaryl ether 8. 
Claisen rearrangement then led to the 6-allyl-8-acetyl hydroxycoumarin analogues (9). Acetyl 
migration to give 6-acetyl-8-allyl hydroxycoumarins proved to be a problematic side reaction. 
Treatment of 9 (X= CI) with 70% sulfuric acid mixture afforded the 8-acetylpsoralens (10) 
(Scheme 6). This procedure was also utilised in the synthesis of 4,5',8-trimethylpsoralen.29 These 
compounds proved to be very versatile, with the acetyl group being converted to the amino 
methyl, a- and (3-hydroxyethyl, a-aminoethyl and 8-methoxypsoralens. Ozonolysis of 9 (X= H) 
in formic acid also led to the corresponding aldehydes, which on treatment with a variety of 
acids, resulted in furan formation to give the acetylpsoralen derivatives 11. 
R 
8: X= CI or H 
(i) Hexamethylenetetramine, CH3COOH, 95°C; 
(ii) DMF, potassium fluoride, allyl bromide or 2,3-dichloro-1-propene; 
(Hi) Diisopropylbenzene, reflux; (iv) 70% H2S04, H20; (v) Formic acid, 03 , (CH3)2S; 
(vi) 85% H3PO4 / 70% H2S04 / polyphosphoric acid or methanesulfonic acid 
Scheme 6 
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Syntheses carried out by Guiotto et a/.18,30 resulted in the preparation of various, new methyl-
substituted isopsoralens. A number of these derivatives were synthesised using the same 
procedures as described by Kaufman24 and Roy and Sen,26 however starting with 5- and 7-
hydroxycoumarins substituted in various positions with methyl groups. These starting materials 
afforded a range of novel isopsoralen derivatives 12 -14 (Scheme 7). 
OH R, 
Xz^J 
12: R,, R2) R3= CH3 or h 
OH 
HO 
H3C QT ^ O QT ^ O 
Scheme 7 
14: R,, R2= CH3 or H 
Additional work by Guiotto et al. made use of a different approach (Scheme 8) in which the 
synthesis of a range of methylated isopsoralens without any substitution in the furan ring was 
achieved. Ozonolysis of the o-allyl hydroxycoumarins (15, 18, and 21) then afforded the 
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corresponding o-hydroxy coumarinylacetaldehydes (16,19, and 22) which were cyclised in the 
presence of phosphoric acid to afford the methyl substituted isopsoralens (17,20, and 23) in ca. 
30-40 % yield (Scheme 8). 
(^ OH CH3 
(15) 
CHO OH CH3 
(0 

























(i) 0 3 , H2/ Pd 10% on CaC03; (ii) 85% H3P04, 100°C 
Scheme 8 
1.3.1.2 Other Synthetic Routes Towards Psoralen Derivatives 
There have been various other synthetic routes towards psoralen derivatives that do not make use 
of o-allyl hydroxycoumarins. MacLeod and Worth31 reported the synthesis of a range of psoralen 
derivatives utilising an intramolecular aldol condensation reaction (Scheme 9). This was 
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achieved via condensation of chloroacetone or phenacyl bromide with 7-hydroxy coumarin (or 
its 4-methyl derivative) to yield compounds 25, which, when refluxed in 0.1N aqueous KOH 
followed by cooling and acidification, afforded the respective psoralens (26). It was found that 
cyclisation occurred so as to afford the linear psoralens only. 
24: R,= CH3 or H 25: Ri= CH3 or H (26) 
R2= CH3 or C6H5 
(i) CH3C0CH2C1 or C6H5COCH2Br, K2C03; (ii) KOH/6 hours, H
+ 
Scheme 9 
In the search for monofunctional psoralen derivatives, as discussed before, a few pyridopsoralens 
have also been prepared.19 Those derivatives with a fused pyridine ring on the pyran of the 
psoralen were accessed via the condensation of 1 -benzyl-3 -ethoxycarbonyl-piperidin-4-one with 
6-hydroxy-2,3-dihydrobenzofuran acetates 27 according to the von Pechmann reaction. 
Aromatisation of the subsequent products using palladium on charcoal afforded the 
pyropsoralens (29) (Scheme 10). 




Psoralens with a pyridine ring fused to the furan ring were prepared using a different route. The 
diaryl ether (32a) was synthesised by condensation of the nitropyridine 30 with the phenol 31 
(Scheme 11). This compound, after reduction to the amine and diazotisation to 32b, decomposed 
in the presence of cupric chloride to give the benzofuro-pyridine (33). Demethylation in boiling 
pyridine hydrochloride and formylation at the 8-position with hexamethylenetetra-amine in 
boiling acetic acid then afforded the aldehyde 34. Condensation with diethyl malonate gave the 
ethoxycarbonyl-pyridopsoralen (35), which, following decarboxylation and hydrolysis, yielded 
the final pyridopsoralen (36) in 49% yield. Analogous compounds, with a benzene ring fused to 
the furan ring have also been prepared using similar chemistry.32 
N 














35: R= C02Et, 
36: R= H 
(i) Cupric chloride, acetone H20, 35°C then reflux; (ii) Pyridine hydrochloride, 220-230°C; 
(iii) Hexamethylenetetra-amine, acetic acid; (iv) Ethanol, diethylmalonate, piperidine, reflux 
Scheme 11 
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A different approach towards the synthesis of angular furanocoumarins was reported by Wulff 
and co-workers.33 They described the synthesis of the isopsoralen derivatives sphondin (42a) and 
heratomin (42b), by utilising the benzannulation reaction of furylcarbene complexes of 
chromium (Scheme 12). Sphondin was prepared by the benzannulation of the 2-furyl complex 
40 with methyl 4-pentynoate 38, by heating in THF for 18 hours. The complex was obtained 
from the ammonium metal acylate 37 (prepared in two steps from furan and chromium 
hexacarbonyl). The product from the reaction (41a), was then dehydrogenated using 2,3-dichloro-
5,6-dicyano quinone (DDQ) to afford sphondin (42a). The synthesis of heratomin was achieved 
using the same methodology from the carbene complex 39. The final dehydrogenation, however, 
did prove problematic and gave a much lower yield of the final psoralen, 42b. 
O" Me4N 








( C O ) 5 C r = ( 
(40) 
(iii) (v) 
41a: R= CH3 
41b: R= CH2CHC(CH3)2 
42a: R= CH3 
42b: R= CH2CHC(CH3)2 
(i) (CH3)2C=CHCH2Br, 20°C; (ii) AcCl, CH3OH; (iii) 38, 85°C/ air, silica gel; 
(iv) 38, CH3OH, 85°C/ C13C02H, PhH, reflux; (v) 4eq. DDQ, PhCH3, reflux 
Scheme 12 
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Also reported recently has been the use of a photochemical aromatic annulation strategy in the 
synthesis of the psoralen bergapten (47).34 In this procedure, the aromatic annulation of ketone 
43 with the siloxyalkyne (44) was achieved by irradiating a degassed solution of the two for 3.5 
hours, followed by refluxing for a further 2 hours (Scheme 13). The resulting silylated product 
(45) was then methylated with methyl iodide and the two silyl ethers cleaved with tetra-«-
butylammonium floride to give the diol (46). Oxidative cylcisation was then achieved using a 
ruthenium complex catalyst. This was followed by dehydrogenation with DDQ, to afford the 



















(i) hv, C1CH2CH2C1, heat; (ii) K2C03, CH3I, acetone, heat; 
(iii) «-Bu4NF, THF, 0°C to R.T.; (iv) cat. H2Ru(PPh3)4, acetone-toluene, 185°C; 
(v) DDQ, benzene, cat./?-nitrophenol, heat 
Scheme 13 
The utilisation of anionic [4+2] cycloaddition strategy towards the synthesis of 8-MOP and its 
isoster has been reported by Murty and Datta.35,36 The preparation involved the annulation of 
methyl 3-(phenylsulfinylmethyl)-2-furoate (48) with enone 49 to give the desired product 50a, 
INTRODUCTION 16 
which was subsequently methylated to give 50b (Scheme 14). Flash vacuum thermolytic 
conditions (500°C, 0.1 mmHg)37 afforded the enone 8-methoxy-l-oxa-5-indacen-7-one (51). 
Treatment of this product with thiophenol in the presence of triethylamine provided the keto 
sulfide 52. This, when exposed to H202/(CH3CO)20/ H2S04 yielded the desired 8-methoxy 





(48) (49) 50a: R= H 















(i) 'BuOLi, -60°C; (ii) FVP (500°C, 0.1 mmHg); 
(iii) PhSH, Et3N; (iv) H202) Ac20, H2S04 
Scheme 14 
The chemistry that has been described thus far represents the main areas of research towards the 
synthesis of psoralen derivatives. There have also been a few other synthetic pathways towards 
these types of compounds. These involve the recent biosynthsesis of some psoralen 
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derivatives,38,39,40 and also the synthesis of some analogues of, for example 8-MOP41 and 4,5',8-
TMP42 via exocyclic modification of the intact parent ring system. 
1.3.2 Synthesis of psoralen heteroanalogues 
A popular area of interest in the synthesis of organic molecules with biological activity often lies 
with the synthesis of heteroanalogues of these compounds i.e. replacement of oxygen atoms in 
the molecule with heteroatoms like nitrogen and sulfur. This has also been of great interest in the 
area of psoralen chemistry, with a vast range of heteroanalogues being synthesised in order to 
prepare psoralen derivatives with a more efficient photochemistry than those traditionally used 
in photochemotherapy. So far the literature reveals that a number of nitrogen, sulfur, and even 
some selenium analogues of psoralen and isopsoralen have been synthesised, and some of these 
new derivatives have been tested with regard to their photophysical, photochemical, and 
photobiological properties. 
1.3.2.1 Synthesis of Nitrogen Analogues 
In the search for heteroanalogues of psoralens with a more efficient photochemistry, there has 
been much work reported on the synthesis of psoralen derivatives containing nitrogen in the 
tricyclic ring system. A novel approach towards the construction of azapsoralen, in which one 
of the ring oxygen atoms was replaced by nitrogen, made use of an intramolecular Diels-Alder 
reaction43 (Scheme 15). In this procedure, the required starting material 55 was prepared in seven 
steps and in good yield from ethyl acetoacetate. The acid-catalysed reaction of this with furan 
gave 56, from which the acetal 57 was prepared. This acetal, on heating with Pd/C, underwent 
cycloaddition with aromatisation to give 58, which was subsequently deprotected to the tricyclic 
ketone 59. A number of treatments: oximation, mesylation, Beckman rearrangement44 and 
dehydrogenation then afforded azapsoralen 61 in a low overall yield. 
The tricyclic ketone 59 could also be converted into psoralen via a Baeyer-Villiger45 oxidation 
reaction, demonstrating the potential value of utilising the Diels-Alder approach as a means of 
synthesising a range of psoralens and their heteroanalogues. A number of substituted 
azapsoralens with a pyridine ring substituting the central benzene ring of the psoralen nucleus 
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have also been synthesised recently. 
(60) (59) (58) 
v H 
(61) 
(i) lOeq. furan,/?-TSOH; (ii) 10% Pd/C, xylene, 200°C; 
(iii) H2NOH.HCl, NaOAc, ethanol, reflux 
Scheme 15 
A new range of pyrrolocoumarin derivatives reported by Quanten et al. ,47 were synthesised from 
m-anisidine (62) (Scheme 16). The first step involved formylation or acetylation with formic acid 
or acetic anhydride to give the substituted amine products 63a and 63b respectively. Reduction 
with LiAlH4 followed by treatment with chloroacetyl chloride, then ring closure with A1C13 
afforded the alkylated amines (66a,b). These iV-alkyl-6-hydroxyoxindoles were then reduced in 
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the presence of LiAlH4 and isolated as the hydrochloride. Pechman condensation with ethyl 
acetoacetate, followed by dehydrogenation then afforded the desired pyrrolocoumarins (69a,b). 







68a: R= CH3 




63a: R= H 
63b: R= CH3 
(v) 
67a: R= CH3.HCI 
67b: R= CH2CH3.HCI 
66a: R= CH3 
66b: R= CH2CH3 
(vii) 
NHR 
64a: R= CH3 
64b: R= CH2CH3 
(iii) 
(iv) ^ N 
CH3O' *NCOCH2Cl 
R 
65a: R= CH3 
65b: R= CH2CH3 
(i) HCOOH or HOAc,(CH3CO)20; (ii) LiAlH4; (iii) C1GH2C0C1; (iv) A1C13; 
(v) LiAlH4.NaBH4; (vi) ethyl acetoacetate, triethylamine, ZnCl2; (vii) Pd/C 
Scheme 16 
A range of methylfiiroquinolinones, with nitrogen replacing oxygen in the pyrone ring, have been 
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synthesised by Guiotto etal.50 Their procedure involved condensation of 2,6-diaminotoluene (70) 
(Scheme 17) with ethylacetoacetate or ethyl methylacetoacetate to give the 7-amino quinolin-2-
ones (71). Formation of the diazonium salts followed by hydrolysis then afforded the 7-hydroxy 
derivatives (72). The formation of the furan ring was accomplished using the approach 
established by Kaufman, which involved allylation, rearrangement, acetylation, bromination and 
cyclisation to afford the methylated fiiro[3,2-g]quinolin-7(8#)-ones (74). 





74: R and Rj= H or CH3 
(72) 
73: Ri= H or CH3 
(i) Ethylacetoacetate, 150°C; 
(ii) H20, cone. H2SO4, sodium nitrite, 0°C then boiling H2S04 
Scheme 17 
Recently a large range of psoralen derivatives with nitrogen substituted at various positions in 
the psoralen nucleus were reported, again by Guiotto and co-workers.51 Making use of variations 
in methodology already discussed, they synthesised a range of various, differently substituted 
psoralen analogues 75 to 82 (Figure 3, R= H or CH3). The antiproliferative activity of these 
analogues was also tested, and some of the compounds synthsesised were found to possess very 
INTRODUCTION 21 
promising biological activity. In fact, the pyrrolocoumarins were found to exhibit significant 
photoreactivity towards nucleic acids, and the largely predominant formation of a 3,4 
photoadduct, (indicated by HPLC and spectroscopic studies), provides strong evidence for the 
monofunctionality of these compounds. 
(78) (79) (80) 
Figure 3 
1.3.2.2 Synthesis of Sulfur Analogues 
The synthesis of psoralen derivatives containing sulfur has not received as much attention as that 
of the nitrogen derivatives. However interest in these compounds has increased in recent years, 
with some derivatives proving to be very efficient DNA photoinactivating agents with great 
promise in photochemotherapy.52 One of the first reported syntheses of a thio-psoralen was by 
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Wellman53 in 1980, who synthesised the sulfur analogue of 4,5',8-TMP, utilising an unusual thio-
Claisen rearrangement as a key step (Scheme 18). The procedure involved conversion of the 
phenol group of 4,8-dimethyl-7-hydroxycoumarin (83) into a thiol in three steps to give the 7-thio 
substituted coumarin (86). Allylation with 2,3-dibromo-l-propene followed by Claisen 
rearrangement then led directly to the psoralen analogue 88 via spontaneous reaction of the newly 










0 ^ 0 
(87) 
(iii) 
(i) NaH,DMF/ (CH3)2NCSC1; (ii) 240-250°C, 40min; (iii) KOH/ HC1; 
(iv) KOH, 2,3-dibromo-l-propene; (v) refluxing dimethylaniline, 48h 
Scheme 18 
Wulff et al?3 also reported the synthesis of the sulfur derivative of sphondin, utilising the same 
benzannulation approach that they used for the synthesis of sphondin (42a) itself (Scheme 12, 
page 14). The synthesis involved the benzannulation of the thio-2-furyl complex (89) with methyl 
4-pentanoate (38) to give the benzannulated thiolactone (Scheme 19). Oxidation of this 







O ^ ^ O (iiO s 
(90) 
(i) THF, 85°C, 18h; (ii) Si02, air; (iii) 2eq. DDQ, toluene, reflux, 4h 
Scheme 19 
Jakobs et al.54 recently reported the synthesis of various sulfur analogues of psoralen using a 
completely different route. Their approach led to the formation of the thio derivative 96, where 
sulfur had replaced both the intracyclic oxygen atoms of psoralen. This compound was 
synthesised using a route which employed 4,6-dibromoisophthalaldehyde (92) as a starting 
material (Scheme 20). Reaction of this compound with one equivalent of potassium 
ethanethiolate yielded the thio alkylated compound 93 which, after reaction with ethyl 2-
mercaptoacetate in basic medium, gave product 94a in 75% yield. 
This compound, after saponification and decarboxylation yielded 6-ethylthio-5-formylbenzo[6]-
thiophene (94b). A Wittig-Horner reaction55 using triethyl phosphonoacetate transformed this 
compound into the ester 95, which was hydrolysed and then cyclised in polyphosphoric acid silyl 









94a: R= COOC2H5 






(i) C2H5SH, K2C03; (ii) ethyl mercaptoacetate; 
(iii) THF, triethyl phosphonoacetate, Ba(OH)2.0,8H2O; (iv) PPSE, 100°C 
Scheme 20 
Later work by the same group reported the preparation of two more thio-psoralens, in which the 
sulfur atom replaced only one of the two oxygen atoms of psoralen.56 The starting material for 
this work was the same as used before, the dibromo compound 92. The synthesis of the first 
analogue 77/-thiopyrano[3,2-/][l]benzofuran-7-one (101) was achieved by first converting one 
of the bromines of 4,6-dibromoisophthalaldehyde (92) into a phenol (97) by reaction with KOH 
in DMSO (Scheme 21). This phenol was then converted into the benzofuran derivative 98a by 
reaction with ethylbromoacetate. Subsequent hydrolysis of the ester followed by decarboxylation 
then led to 98b. Nucleophilic substitution of the bromine atom by ethanethiolate afforded the 
thioether 99, which was transformed into 100 as before. Hydrolysis and cyclisation of the acid 
in the presence of PPSE then afforded the desired product 7//-thiopyrano [3,2-f\ [ 1 ]benzofuran-7-
one (101) in 43% yield. 
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98a: R= C02C2H5 









(i) KOH, DMSO, 90°C; (ii) Ethylbromoacetate, DMF; (iii) K2C03, ethanethiol; 
(iv) THF, triethyl phosphonoacetate, Ba(OH)2.0,8H2O; (v) PPSE, 120°C 
Scheme 21 
The second analogue, 2/f-thieno[3,2-g][l]benzopyran-2-one (105), where sulfur replaces the 
oxygen of the furan ring (Scheme 22), was prepared by reacting 92 with lithium methanolate in 
methanol to give the required intermediate 102 . This was reacted with potassium ethylthio 
glycolate to afford 103a. Saponification and decarboxylation consequently afforded 103b, which 
was converted to the vinylogous acid 104 via a Knoevenagel reaction.57 Cyclisation in the 
presence of PPSE afforded the desired analogue 2//-thieno[3,2-g][l]benzopyran-2-one (105) in 
60% yield. 
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103a: R= C02C2H5 




(i) Li, methanol, reflux; (ii) K2CO3, ethyl mercaptoacetate; 
(iii) Pyridine, piperidine, malonic acid; (iv) PPSE, 170°C 
Scheme 22 
Further research by Jakobs and Christiaens58 also led to the synthesis of a new analogue of 
isopsoralen using a different route (Scheme 23). The known ketone, tetrahydro-4,5,6,7-
benzofuran-4-one (106) was converted via the Vilsmeier-Haack reaction59'60 into the chloroformyl 
product 107. Nucleophilic substitution of the chlorine atom by the ethanethiolate anion yielded 
a thioether (108), which was aromatised with 2,3-dichloro-5,6-dicyano quinone (DDQ) to give 
109. Preparation of the ester, followed by saponification and cyclisation in PPSE afforded the 













(i) DMF, 1,1,2-trichloroethane, phosphorus oxychloride; (ii) K.2CO3, ethanethiol; 
(iii) DDQ; (iv) Triethyl phosphonoacetate, Ba(OH)2.0,8H2O; 
(v)PPSE, 100°C 
Scheme 23 
Mosti and co-workers61 have also recently reported the synthesis of a thio-isopsoralen analogue 
via a method in which the thio-furan ring was present in the starting material and subsequent 
synthesis of the pyrone ring completed the isopsoralen (Scheme 24). In this procedure the 
precursor 112 (obtained by refluxing the available ketone in AfJV-dimethylformamide 
dimethylacetal) was reacted with dimethyl malonate to give 113. This was then aromatised in 
the presence of DDQ. The ester (114) was converted to the corresponding carboxylic acid and 
decarboxylated by refluxing in quinoline containing a catalytic amount of copper powder to 
afford the thio-isopsoralen analogue 116 in 70% yield. Photobiological testing of this analogue 
showed a strong inhibition of T2 bacteriophage infectivity as well as significant repression of 
DNA synthesis in Ehrlich ascites cells. The analogue also appeared to be free of any of the 















(i) Me02CCH2C02Me; (ii)DDQ; (iii) HC1/CH3C02H; (iv) Quinoline, Cu 
Scheme 24 
A novel approach to sulfide derivatives of psoralens, where sulfur is incorporated as a substituent 
in the 5'-position instead of in the psoralen nucleus, has recently been reported in the literature.62 
The introduction of the acetyl group into the 8-position was achieved via a Fries rearrangement 
of the acetate of 7-hydroxycoumarin to give 117 (Scheme 25). The ethyl carbazone of this 
compound was converted using the Hurd-Mori synthesis63 into the 1,2,3-thiadiazole 118. 
The tandem decomposition/cyclisation reaction was achieved using the system potassium 
carbonate/tetrabutylammonium bromide/acetone, and quenching with methyl iodide. This 
afforded the isopsoralen derivatives 119 in ca. 30-35% yields. The linear psoralen could also be 








(i)NH2NHCOOEt; (ii) SOCl2, 25°C; (iii) base, RX, 25°C 
Scheme 25 
The synthesis of sulfur analogues of psoralens and isopsoralens has become an important area 
in the field of psoralen chemstry, with an increased interest in recent years towards the synthesis 
of these types of compounds. The fact that some of these compounds have exhibited potent 
photobioligical activity means that there is still a lot of work to be done in this area, with the 
synthesis of a greater variety of analogues for biological testing a definite domain of interest. 
1.3.2.3 Synthesis of Selenium Analogues 
Until recently, no study on the effect of a heavy atom like selenium on psoralen photo- reactivity 
had been reported. One of the first reported syntheses of a seleno-psoralen derivative was made 
in 1992 by Jakobs, Christiaens and Renson.54 They reported on the synthesis of three possible 
hetero-psoralens where selenium, along with sulfur, replaced the two intracyclic oxygen atoms 
of psoralen. 
The basic starting compound for their work was 4,6-dibromoisophthalaldehyde (92). This 
compound was found to be a very versatile starting material for the synthesis of all sulfur and 
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selenium analogues of psoralen, as has already been seen in the section on sulfur analogues. The 
synthetic procedure is very similar to that used for the synthesis of the sulfur analogues already 
discussed (namely compounds 96,101,105). 
Reaction of the starting material 4,6-dibromoisophthalaldehyde (92) with one equivalent of 
potassium ethanethiolate yielded compound 93 (as for the sulfur analogue synthesis, see Scheme 
20, page 24) which was converted into the product 120a (Scheme 26). This compound, after 
saponification and hydrolysis yielded 6-bromo-5-formylbenzo[6]thiophene (120b). The bromine 
atom of 92 was then substituted by methaneselenolate to afford the selenoether (121) in 69% 
yield. Reaction of aldehyde 121 with triethyl phosphonoacetate yielded the ester 122. 
Saponification to the corresponding acid, followed by cyclisation then afforded the desired 






120a: R= CH2COOC2H5 









(i) K2C03, C2H5SH; (ii) DMF, ethyl mercaptoacetate; (iii) K2C03, acetonitrile, methaneselenol; 
(iv) THF, triethyl phosphonoacetate, Ba(OH)2.0,8H2O; (v) PPSE, 100°C 
Scheme 26 
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The seleno-psoralen analogue 127 was also synthesised by successively reacting the dibromo 
starting compound (92) with one equivalent of potassium ethanethiolate and one equivalent of 
potassium methaneselenolate (Scheme 27) to afford 4-ethylthio-6-methylselenoiso 
phthalaldehyde (124). This was then refluxed in ethyl bromoacetate and the seleno ether obtained 
cyclised to the benzofuran derivative 125. The ester was saponified and decarboxylated. The 
aldehyde 125 was then transformed into ester 126 as before; hydrolysis and cyclisation of this 
compound then afforded the desired product 2#-selenolo[3,2-g][i]benzothiopyran-2-one (127) 












(OK2CO3, DMF, ethanethiol, 24hrs, then methaneselenol; (ii) Ethylbromoacetate, reflux; 
(iii) THF, triethyl phosphonoacetate, Ba(OH)2.0,8H2O; (iv) PPSE, 100°C 
Scheme 27 
The third compound, in which selenium replaced both oxygen atoms (Scheme 28) was accessed 
by reacting 4,6-dibromoisophthalaldehyde (92) with one equivalent of potassium methane 
selenolate. The product was refluxed in ethyl bromoacetate to afford the precyclic selenoether 
(128) which was cyclised using K2C03. The resulting benzoselenofuran (129) was reacted with 
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potassium methaneselenolate to afford the selenoether (130a), which was then saponified and 
decarboxylated to afford 130b. From this compound was prepared the vinylogous ester via a 
Wittig-Horner type reaction. It was subsequently saponified and cyclised in PPSE to afford the 
final product, 7#-selenolo[3,2-g][/]benzo-selenopyran-7-one (132) in 34% yield. 
92 (0 
OHC CHO 












130a: R= COOEt 
130b: R= H 
(i)K2C03, acetonitrile, methaneselenol; (ii) Ethylbromoacetate, reflux, K2CO3; 
(iii) K2CO3, acetonitrile, methaneselenol; (iv) THF, triethyl phosphonoacetate, Ba(OH)2.0,8H2O; 
(v)PPSE, 100°C 
Scheme 28 
Some work published a few years later by the same research group56 involved the synthesis of a 
further range of seleno-psoralen analogues, but where the selenium atom replaced only one of 
the two endocyclic oxygen atoms of psoralen. 
The synthesis involved using the same dibromo starting material (92). The synthesis of the first 
analogue 7//-selenopyrano[3,2-f] (7]benzofuran-7-one (135) was achieved by first converting 4,6-
dibromoisophthalaldehyde (92) into the phenol (97) (Scheme 29) by reaction with KOH in 
DMSO as described before. The phenol was then transformed into the benzofuran derivative 
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(98a) by reaction with ethylbromoacetate; hydrolysis and decarboxylation of the ester then led 
to 98b. Nucleophilic substitution of the bromine atom by methaneselenolate then afforded the 
selenoether (133), which was transformed into the ester (134) as before. Hydrolysis and 
cyclisation of the acid in the presence of PPSE afforded the desired product 1H-







98a: R= COOEt 
98b: R= H 
(135) 
(v) 








(i) KOH, DMSO, 90°C; (ii) K2C03, DMF, ethylbromoacetate, reflux; 
(iii) K2C03, DMF, methaneselenol; (iv) THF, triethyl phosphonoacetate, Ba(OH)2.0,8H2O; 
(v)PPSE, 150°C 
Scheme 29 
The final psoralen analogue synthesised (139) consisted of a selenium atom in place of the 
oxygen atom of the furan ring. This was accessed by initially reacting 4,6-dibromoiso 
phthalaldehyde (92) with one equivalent of lithium methanolate in methanol to yield the ether 
102 (Scheme 30). The bromine was replaced by selenium as before to afford the seleno ether 
(136a). Reaction with ethylbromoacetate then afforded 136b, which was subsequently cyclised 
in basic medium to afford the selenophene derivative (137a). The ester was hydrolysed and 
decarboxylated to give 137b, which was converted into the ester (138) and cyclised using the 
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same methods previously mentioned. This afforded the final product 2//-selenolo[3,2-
g][i]benzo- pyran-2-one (139). However, the yield of the final reaction was found to be only 19 
% owing to polymer formation; a higher yield was obtained by first demethylating 137b into the 
benzofuran (137c) with lithium chloride. The phenol was then transformed into the final product 





RiSe^ " ^ OCH3 
136a: Rx= CH3 








137a: R2= COOEt, R3= CH3 
137b: R2= H, R3= CH3 
137c: R2= R3= H 
(i) Lithium, methanol, reflux; (ii) K2C03> DMF, methaneselenol; (iii) K2C03, DMF; 
(iv) THF, triethyl phosphonoacetate, Ba(OH)2.0,8H2O; (v) PPSE, 150°C 
Scheme 30 
To date, these methodologies have been the only reported synthesis of selenium analogues of 
psoralen, and photobiological52 and other testing (spin trapping and electron spin resonance 
spectroscopy)66 have revealed that these analogues show great promise in the use of 
photochemotherapy. Up to now there has been no reported synthesis of analogues of isopsoralen, 
so the synthesis and photobiological testing of these types of compounds will be of great interest 
in this field of research. 
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1.4 AIMS OF THIS RESEARCH PROJECT 
As has already been demonstrated, the synthesis of the wide range of furocoumarin derivatives 
known as psoralens and isopsoralens is an important area of research in the improvement of the 
biological activity of these important compounds. It has already been shown that two of the most 
important areas in this field involve the synthesis of the monofunctional isopsoralen derivatives, 
as well as the preparation of any possible hetero analogues, as these have been shown, in some 
cases, to possess potent photobiological activity. The aim of this project was thus to attempt to 
develop and optimise methodology that could lead to the preparation of a range of new 
isopsoralen derivatives incorporating both oxygen, sulfur, and hopefully even selenium atoms in 
the parent isopsoralen nucleus. 
2. DISCUSSION 
This project has been concerned with the development of a synthetic route towards the 
preparation of a number of isopsoralen derivatives. In the discussion which follows, attention will 
be focussed on the synthetic steps which led towards the final compounds synthesised. The 
mechanistic detail of some of these transformations will be discussed in order to afford a greater 
understanding of the processes involved. Selected proton and carbon NMR spectra for some of 
the compounds synthesised will be discussed. 
2.1 PREPARATION OF OXYGEN ANALOGUES 
2.1.1 Synthesis of o-allyl hydroxycoumarins 
The allyl aryl ether (141) was synthesised by reaction of the substituted phenol (140)with an alkyl 
halide, in this case, allyl bromide in the presence of a base (K2C03).The reaction afforded the 
allyl aryl ether, 7-(allyloxy)-2i/-chromen-2-one (141) in ca. 90% yield (Scheme 31). The ether 
was subsequently subjected to a thermal Claisen rearrangement reaction,67,68 affording the 8-
allyl-7-hydroxy-2//-chromen-2-one (142) in ca. 80% yield. 
(i) K2C03 , acetone, reflux; (ii) JV.AT-diethylaniline, 220°C 
Scheme 31 
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2.1.1.1 The Claisen Rearrangement Reaction 
The Claisen rearrangement67,68 is a thermally induced rearrangement of an allylic aryl ether into 
the corresponding o-allylphenol. If both ortho positions are filled, the allyl group migrates to the 
para position. Migration to the meta position has not been observed, and if both the ortho and 
para groups are filled, the reaction has been shown to not take place at all. The mechanism for 
this reaction is a concerted pericyclic [3,3] sigmatropic rearrangement (Scheme 32), with the O 
bond migrating over 3 atoms. As Scheme 32 shows, the first step involves the slow, rate 
determining migration of the allyl group to the ortho position of the corresponding ketone 
product (141a). Subsequent keto-enol tautomerisation then takes place to afford the alcohol 142, 







Evidence for this type of mechanism has been supported by the absence of crossover products 
when mixtures are heated, the fact that the reaction is first order in ether, and the presence of the 
allylic shift (demonstrated by 14C labelling experiments), which is required by this mechanism. 
Since the mechanism does not involve ions, it is not greatly dependant on the presence or absence 
of substituent groups on the ring. However, the rate of the reaction has been shown to be greatly 
influenced by the choice of solvent in which it is run.69 
The allyloxy coumarin (141, Scheme 32) contains two vacant ortho positions to the hydroxyl 
group, it would therefore be expected that rearrangement would afford a mixture of the two 
possible regioisomers i.e. the allyl group migrated to both the 6- and 8-positions. However this 
is not the case, instead there is total regioselectivity in the reaction affording the 8-allyl isomer 
(142) exclusively. This occurrence has also been noted previously in the literature,24 where it was 
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shown that the 8-position is the most reactive during the Claisen rearrangement. This is 
somewhat surprising due to the fact that the mechanism has been shown to be independant of 
substituents on the aromatic ring. Rearrangement to the 6-position (leading to the synthesis of 
psoralens) is only possible when there is a group blocking the 8-position. 
The position of the allyl group in the 8-position was confirmed by Correlation Spectroscopy 
(COSY) of 8-allyl-7-hydroxy-2if-chromen-2-one (142) (Figure 3).f The coupling between 
protons H-5 and H-6 in this spectrum clearly indicates that the allyl group did, in fact, migrate 
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Figure 3: 500 MHz COSY Spectrum of 8-allyl-7-hydroxy-2#-chromen-2-one (142) in CDC13 
fIUPAC numbering will be used when discussing NMR spectra. 
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Nowhere in the literature could an explanation for the observed regioselectivity be found, there 
seems to be only an acceptance and utilisation of this fact but no attempt to propose any possible 
explanation for it. In order to account for the regioselectivity of this reaction, some molecular 
mechanics (MM2) and electronic structure theory (AMI) calculations were performed on the 
coumarin systems studied. The calculations were performed using Hyperchem70 and revealed 
some interesting results which seem to coincide with the observations for the rearrangement 
reaction. It must be noted that in order for the Claisen rearrangement (as with most pericyclic 
reactions) to take place there must be an overlap of an electronically occupied molecular orbital 
(usually the HOMO or Highest Occupied Molecular Orbital) with an unoccupied molecular 
orbital (this is usually the LUMO, or Lowest Unoccupied Molecular Orbital). Only in this way 
can there be the donation of electrons from one carbon atom to another as is required for the 
formation of a new carbon-carbon bond, as shown by the mechanism for the reaction. 
The calculated molecular orbitals for the coumarin systems examined (Figure 4) revealed the 
following:-
(i) the HOMO -2 orbital [Figure 4 (A)] is of it-symmetry and has non vanishing 
amplitude on the allyl group, suggesting that the terminal alkene in fact acts as the 
electron-donor; the electron-acceptor is thus carbon 8 of the aromatic ring of the 
coumarin. 
(ii) a plot of the LUMO for the coumarin system, [Figure 4 (B)] reveals that this 
molecular orbital does not lie over the carbon 6 atom which, remembering that 
this molecular orbital is an indication of the area in which any donated electrons 
can be placed (since it is unoccupied by any electrons), accordingly suggests that 
this carbon cannot act as the electron acceptor for the reaction. This consequently 
provided a tentative explanation for the observed regioselectivity in this reaction. 
These results together with our observations clearly indicate that there must be a significant 
influence by substituent groups on the mechanism of this reaction. 
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Figure 4: Figure of the Squares of the Electron Probability plots for the HOMO -2 (A) and the 
LUMO (B) molecular orbitals for 7-(allyloxy)-27/-chromen-2-one (141). 
2.1.2 Synthesis of Isopsoralen Analogues 
2.1.2.1 Synthesis of 8-methoxy-8,9-dihydro-2//-furo[2,3-^]chromen-2-one (150a) 
In order to complete the formation of the furan ring, 8-allyl-7-hydroxy-2i/-chromen-2-one (142) 
was subjected to ozonolysis in order to cleave the terminal alkene of the allyl group and 
subsequently generate an aldehyde (Scheme 33). 
The oxidative cleavage of olefins by ozonolysis is a well established transformation in organic 
chemistry45 and is used widely for synthetic purposes. The process results in the cleavage of a 
double bond, usually under extremely mild conditions (at or below -78°C),1 the products of this 
cleavage being aldehydes/ketones or their peroxidic products (in the case of aldehydes, their 
oxidative products, the carboxylic acids). 








(i) 03, THF,-78°C, 1.5 hrs; 
(ii) Dimethylsulfide, -10°C to 0°C 
Scheme 33 
The mechanism of ozonolysis has been extensively investigated in the literature. Criegee71 
proposed a mechanism (Scheme 34), which has been widely accepted, and has been substantiated 
by subsequent l 70 NMR spectroscopic experiments.72 The mechanism is believed to involve the 
addition of the ozone molecule to the alkene to form a molozonide (144), (Scheme 34). This is 
a highly unstable system and immediately decomposes into a carbonyl compound (146) and a 
'carbonyl oxide' (145) which themselves immediately condense again to form the more stable 
ozonide (147). Hydrolysis or (preferably) reduction of this ozonide affords the two carbonyl 
products, in the cases where an aldehyde would be formed, the equivalent of peroxide generated 
by the hydrolysis produces a carboxylic acid instead, it is thus preferable to use the reductive 
work up to reduce the peroxy link. 
Reducing agents such as Zn/AcOH, Me2S, Ph3P and Me3P have all been used,
45 however in this 
project Me2S was the reagent of choice. There are a number of advantages to using this reagent;
73 
it is highly selective, the reduction is performed under neutral conditions, excess dimethylsulfide 
is easily removed by evaporation and the by-products, methanol and dimethyl sulfoxide, induce 








Ketone Products n47"> 
Scheme 34 
2.1.2.1.1 Formation of the Hemiacetal and Subsequent Nucleophilic Substitution 
The aldehyde (143) was, as expected, never isolated, and instead cyclisation took place between 
the phenol moiety and the carbonyl carbon resulting in the formation of a hemiacetal (149) 
(Scheme 35), the mechanism of this reaction involves attack by the lone pair of electrons on the 
oxygen atom of the hydroxyl group onto the 6+ carbonyl carbon, followed by protonation of the 
negative carbonyl oxygen to form the cyclised product (148). The positively charged oxygen 
atom subsequently loses its proton to form the hemiacetal (149). 
This hemiacetal, in the presence of methanol, underwent subsequent nucleophilic substitution 
of the hydroxyl group with the methoxy nucleophile of the methanol, resulting in the formation 
of the novel 5'-methoxy isopsoralen derivative, 8-methoxy-8,9-dihydro-2//-furo[2,3-/2]chromen-
2-one (150a) as a racemic mixture of the R and S enantiomers.The hemiacetal (149) was able to 
be isolated from reactions carried out in THF without the addition of any alcohol, and was shown 







Compound 150a was characterised by X-Ray Crystallography (Figures 5 and 6) and NMR 
spectroscopy (Figures 7 and 8). From the Crystal structure it can be observed that the isopsoralen 
derivative lies in the Monoclinic crystal system with the space group being P2j/a. The two 
enantiomers are related by a centre of inversion in the space group. The crystal structure also 
shows the expected planarity of the molecule, and in the solid state the molecules are shown to 
be packed tightly together in the unit cell, indicating the potential for n -stacking of these 
compounds and hence the potential for intercalation into the DNA double helix. 






Figure 6: Diagram showing the packing of 8-methoxy-2//-furo-[2,3/i]chromene-2-one 
(150a) in the unit cell. 
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Figure 7: 500 MHz 'H and 125 MHz 13C Spectra of 8-methoxy-8,9-dihydro-2//-furo[2,3-/7] 
chromen-2-one (150a) in CDC13. 
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The proton NMR spectrum for 8-methoxy-8,9-dihydro-2//-furo[2,3-/z]chromen-2-one 150a 
(Figure 7) shows clearly the presence of the methoxy methyl (a singlet at 3.5 ppm) and also the 
four aromatic protons (four doublets between 6.2 and 7.6 ppm). There is also an interesting 
coupling effect between the 9-CH2 and the proton on the stereogenic carbon (C-8). The two 
protons of the CH2are diastereotopic and thus are split into two separate signals for each proton. 
A magnification of the spectrum (Figure 8) show the geminal coupling between these two 
protons at 17.1 Hz, resulting in a pair of doublets. Further coupling to the 8-H proton further 
splits each of these signals into a doublet of doublets, with the magnetic non-equivalence of Ha 
and Hb giving rise to different coupling constants for these two signals. 
This coupling effect has been rationalized by the work of Karplus.74,75,76 He stated, on the basis 
of calculations, the dependance of the vicinal coupling constant on the dihedral angle 0 . From 
these calculations, he determined that the vicinal coupling constant can be approximated by the 
equation: 
JHH. = 4.22 + (-0.5) cos 3> + 4.5 cos $ 
Using Hyperchem, an energy minimised structure of (150a) was calculated. This structure 
computed a dihedral angle of 132.5° for Ha, and a much smaller one of only 7.8° for Hb. Both 
the R and S enantiomers revealed similar calculated dihedral angles. Subsequent analysis of the 
'H NMR spectrum then showed a coupling constant of 2.3 Hz for Ha, and a larger coupling 
constant of 6.6Hz for Hb. These values compare favourably with those obtained using the 
Karplus equation, which equates /values of 4.2 Hz and 8.1 Hz for Ha and Hb respectively. 
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Figure 8: Partial 500 MHz 'H NMR spectrum for 8-methoxy-8,9-dihydro-2#-furo[2,3- h] 
chromen-2-one(150a) showing the splitting of the 9-CH2 and the 8-CH protons. 
2.1.2.2 Investigation of Other Nucleophiles 
Due to the interest in these compounds, extension of this approach to include other nucleophiles 
was examined. Ethanol, isopropanol and fert-butanol were all successful in producing the 
subsequent 5'-substituted isopsoralen derivatives (150b-d) in ca. 65-75% yields. Purification of 
these types of compounds on silica proved problematic^ Fortunately, however, these compounds 
are crystalline and hence, in most cases the need for chromatography proved unnecessary. 
degradation was observed on prolonged exposure to silica gel. 
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(i) 
^ / ^ 
ROH 
(142) (149) 150b: R= CH3CH2 
150c: R= (CH3)2CH 
150d: R= (CH3)3C 
(i) THF, -78°C, 03, then dimethylsulfide, -10°C to R.T. 
Scheme 36 
The NMR spectrum of 8-ethoxy-8,9-dihydro-2//-furo[2,3-/j]chromen-2-one (150b, Figure 9) 
revealed some interesting splitting patterns for the methylene protons of the ethoxy group. The 
splitting patterns for the 9-CH2 and 8-CH protons are similar to those seen for 8-methoxy-8,9-
dihydro-2//-furo[2,3-/i]chromen-2-one (150a, Figure 8), with the two protons on carbon 9 each 
being split into a doublet of doublets with different coupling constants due to the magnetic non-
equivalence of these two protons. 
However, in addition to these signals there was also a splitting of the two C-H protons attached 
to the l'-carbon. This was displayed as two multiplets between 3.2 and 3.5 ppm (Figure 9), and 
comes about because these two protons are in fact diastereotopic and hence have different 
chemical shifts. The fact that these protons are diastereotopic despite the absence of a stereogenic 
centre is well known in this type of system and has been documented before.75 The expanded 
section clearly shows the multiplets as a doublet of quartets, which arise from the geminal 
coupling of the two protons Ha and Hb (9.4 Hz), followed by independent coupling with the 
terminal methyl group (J= 7.1 Hz). The methyl signal is, as expected, a clear triplet showing a 
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Figure 9: 500 MHz 'HNMR spectrum of 8-ethoxy-8,9-dihydro-2//-furo[2,3-/z]chromen-2-one 
(150b) showing splitting patterns for the l'-CH2 protons. 
A range of other nucleophiles including ethanethiol, acetic acid and phenol were also utilised in 
order to explore the potential of this reaction, however it was observed that in fact, no subsequent 
nucleophilic substitution took place, with the hemiacetal being isolated instead. This may be 
attributed to the fact that these compounds are not as strongly nucleophilic as those used 
previously, and thus were not able to induce the nucleophilic substitution that had previously been 
achieved. 
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A recent report by Roels and Metz77 describe the use of the Dess-Martin periodinane (DMP),78,79 
(which is a widely used reagent for the oxidation of primary and secondary alcohols to aldehydes 
and ketones), as a crucial co-reagent for the acylation of the hemiacetal tetrahydro-2//-pyran-2-ol 
(151) (Scheme 37). They found that when 151 was stirred in acetic acid no conversion of the 
hemiacetal took place, however in the presence of DMP there was complete transformation of 
hemiacetal 151 into 154 in 15 minutes at room temperature. 
Their proposed mechanism for the reaction first depicts a ligand exchange between one of the 
acetoxy groups of DMP and the hemiacetal (151) to afford the intermediate (152). This 
intermediate then generates an oxonium ion (153) which reacts with the acids to form the 
acylated lactols (154, R= Me, Et). 
Conducting an approach such as that carried out by Roels and Metz may allow for the inclusion 
of other nucleophiles into the hemiacetal system (149) and could hopefully lead to the 
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(154) 
(i) DMP, HOAc, CH2C12, 15min R.T.; 
(ii) R-C02H (R=Me, Et) 
Scheme 37 
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2.1.2.3 Synthesis of 2//-furo[2,3-/z]chromen-2-one (156) 
The hemiacetal (149) was transformed into the known isopsoralen 2//-furo[2,3-/j]chromen-2-one 
(156)33 by performing a dehydration reaction (Scheme 38) on the hemiacetal. The starting 
compound was dissolved in toluene containing a catalytic amount of /7-toluenesulfonic acid as 
a dehydrating agent. In the dehydration reaction, the hydroxyl group is protonated by the catalyst 
to form the protonated intermediate 155, subsequent loss of water results in the formation of a 
new double bond in the furan ring, affording 2//-furo[2,3-/z]chromen-2-one (156) in quantitative 
yield. A Dean and Stark apparatus was used to facilitate the removal of water, which is crucial 
in order for this reaction to succeed. 
(i) Toluene, p-toluenesulfonic acid, reflux 
Scheme 38 
2.1.2.4 Investigation of Substituted Allyl Groups 
Once the synthetic route to synthesise the range of 5'-substituted isopsoralen derivatives (150a-
d) had been established, it was decided to extend the scope of this approach by using different, 
substituted allyl groups in order to include other functionality in the furan ring system and to 
investigate the possible effects such a substituent might have on the subsequent nucleophilic 
substitution (Scheme 39). The use of two substituted allyl groups was proposed, namely a 
methyl- and a methyl ester-substituted allyl group. 
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R'OH 
R= CH3, C02CH3 
Scheme 39 
2.1.2.4.1 Synthesis of 8-methoxy-8-methyl-8,9-dihydro-2//-furo[2,3-/2]chromen-2-one (163) 
In order to introduce the R-functionality, 3-bromo-2-methyl-l-propene was reacted with the 7-
hydroxycoumarin (140) to afford the allyl aryl ether 157 (Scheme 40). Subsequent Claisen 
rearrangement led to its rearranged product 158, which, when subjected to ozonolysis and 
treatment with methanol afforded a compound which at first was thought to be the equivalent 
hemiacetal as had been isolated previously. However, on closer inspection of the 13C NMR data, 
it was found to be the ketone derivative, 7-hydroxy-8-(2-oxopropyl)-2//-chromen-2-one (159) 
obtained after reductive workup following the ozonolysis reaction. Thus, in this instance, 
cyclisation did not take place between the hydroxyl group and the carbonyl carbon. 
CH3 




CH3 (157) CH3 (158) 
(iii) 
(iv) 
(i) K2CO3, acetone, reflux, (ii) AfJV-diethylaniline, reflux; 
(iii) 03, THF,-78°C, then dimethylsulfide,-10°C to R.T.; (iv) CH3OH, heat 
Scheme 40 
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There are two possible explanations for the failure of the cyclisation. Firstly, the methyl group 
of the ketone would have a positive inductive effect of electron density towards the carbonyl 
carbon. This would subsequently result in this carbon being less electrophilic when compared 
with the carbonyl carbon of the aldehyde (143), and therefore decreasing the susceptibility for 
attack by the lone pair on the oxygen of the hydroxyl group toward the carbonyl carbon. Another 
reason for the lack of cyclisation could be due to the steric bulk of the methyl group itself, with 
steric interactions between the methyl and hydroxyl groups preventing nucleophilic attack from 
occurring at the optimum Burgi-Dunitz trajectory80,81 and thus hindering the reaction. 
In order to obviate the problems associated with the cyclisation step, /?-toluenesulfonic acid was 
utilised as a catalyst (Scheme 41) in order to induce cyclisation. In this approach, the catalyst 
would protonate the carbonyl oxygen of 159, leading to the formation of the carbocation (160), 
this will then force the lone pair of electrons on the hydroxyl oxygen to attack this carbon and 
thus cyclisation occurs. This indeed occurred and the hemiacetal (161) obtained from this 
cyclisation then underwent a dehydration reaction in the presence of the catalyst in the same 
manner as shown before (Scheme 38, page 51) and afforded the known isopsoralen derivative 




The success of this procedure then prompted the speculation that if this same technique was 
repeated using methanol as a solvent, nucleophilic substitution of the hydroxyl group with the 
methoxy nucleophile should occur in preference to dehydration, to give the expected substituted 
isopsoralen derivative. This approach was attempted (Scheme 42) and the reaction did, in fact, 
afford the expected isopsoralen derivative, 8-methoxy-8-methyl-8,9-dihydro-2//-furo[2,3-/z] 
chromen-2-one (163) in quantitative yield as a racemic mixture. This compound was 











C H ! " ( 1 » C H > 




r~Tr ' I ' 1 I ' 1 1 1 1 1 1 1 1 ' 1 1 1 1 1 
7.5 6.5 5.5 
' I ' ' ' ' I r ' ' ' I 
4.5 3,5 
CH, 
Figure 10: 500 MHz 'H NMR spectrum of 8-methoxy-8-methyl-8,9-dihydro-2//-furo[2,3-/2] 
chromen-2-one (163) in CDC13. 
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2.1.2.4.2 Synthesis of methyl 2-{[(2-oxo-2//-chromen-7-yl)oxy]methyl} acrylate (169) 
The methyl 2-(chloromethyl)acrylate (168) required in order to introduce an ester functionality 
into the system (Scheme 45) was synthesised using the Baylis-Hillmann reaction.82 The Baylis-
Hillmann reaction involves the coupling of an aldehyde and an acrylate ester (Scheme 43), 
catalysed by a tertiary amine base, usually 1,4-diazabicyclo[2.2.2]octane (DABCO).The reaction, 
which tends to be rather slow (sometimes taking 4-7 days or longer, for completion) has found 
wide application in the synthesis of a large range of natural products including necic acids.83 
O 
A 
0 OH O 
+ 
DABCO 
OR' R ^OR 
Scheme 43 
A kinetic and mechanistic study undertaken by Bode and Kaye,84 led to the proposal of a 
mechanism for the reaction which was consistent with the experimentally determined data and 
also with earlier suggestions put forward in a review of the Baylis-Hillman reaction by Drewes 
and Roos.82 The mechanism, as applied to the reaction carried out in this project (Scheme 44), 
involves an addition-elimination sequence initiated by nucleophilic attack of the tertiary amine 
on methyl acrylate (164) to form the transient zwitterionic enolate species which subsequently 
attacks the electrophilic paraformaldehyde to afford the intermediate adduct (165). The formation 
of this intermediate is thought to be the rate-determining step. Proton transfer and elimination 
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The next step involved the activation of 166 to facilitate the reaction with 7-hydroxycoumarin 
(140), achieved by replacing the hydroxyl group with a halide atom. One advantage found here 
is that there is no need to separate out the coupled product (166) and the ether (167) since this 
ether is also converted into the halide under the same conditions.85 Thus the crude mixture of 
products 166 and 167 can be used for the subsequent halogenation step. Initial attempts to 
convert the hydroxyl into a bromide using HBr were unsuccessful, however conversion to the 
chloride was achieved by reaction with thionyl chloride to afford 2-chloromethylacrylate (168) 




(166) (167) (168) 
(i) DMF, benzene, thionyl chloride, 60°C; 
(ii) H20(s) 
Scheme 45 
Once the 2-chloromethylacrylate (168) was synthesised, it was treated with 7-hydroxy coumarin 
(140) in the presence of potassium carbonate to afford the allyl aryl ether (169) in 95% yield 
(Scheme 46). The next intended step was to perform the Claisen rearrangement on methyl 2- {[(2-
oxo-2//-chromen-7-yl)oxy]methyl} acrylate (169) so as to obtain the rearranged product (170). 
However, this step proved to be surprisingly difficult despite previous literature precedence to 
support this reaction.86 
(140) C02Me (169) 
(i) THF, NaH, then 168, reflux, 3hrs. 
Scheme 46 
Unfortunately, normal thermal conditions (refluxing A îV-diethylaniline) had no effect when 
trying to perform the Claisen rearrangement on the coumarin 169, and hence the reaction was 
repeated using a variety of other conditions,45'87 namely:-
(i) Refluxing N, JV-diethylaniline containing A1C13 as a catalyst; 
(ii) Refluxing trifluoroacetic acid; and 









None of these conditions, however, were successful in inducing the rearrangement to occur. A 
probable explanation for the failure of the rearrangement may be the competing delocalisation 
within the system (Scheme 47), resulting in the formation of the enolate of the cc,|3-unsaturated 
ester. This has the effect of creating the system displayed by compound 171, where the negative 
charge has been delocalised over the entire ester functionality. It will be noticed that the 
resonance structure formed by pathway b can still undergo rearrangement since the allyl group 
is still in place. However, a predominance of the resonance structure formed by pathway a 
would definitely hinder rearrangement since this structure is unable to undergo rearrangement. 
The enolate species is stabilised by the presence of protons in solution, thus carrying out the 
reaction in an aprotic solvent may lead to the formulation of reaction conditions which facilitate 
the desired rearrangement reaction. 
Scheme 47 
The presence of the system displayed by coumarin 171 has been corroborated by calculations 
performed on the coumarin 169 using Hyperchem. These calculations, as were performed on the 
previous allyloxy coumarin systems, revealed similar HOMO-LUMO plots as before, (cf. 
Figure 4, page 40) suggesting that the reaction could occur and should afford the same 
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regioselectivity as noted before. However, inspection of the charge distribution on each atom 
for all three systems showed that the charge on the terminal vinyl carbon of coumarin 169 was 
less negative than that of the same carbons on the other two coumarin systems (Table 2). This 
is indicative of the representation shown in Scheme 47 where the negative charge has been 
delocalised, thus making the alkene a substantially less efficient electron donor and 
consequently lowering the probability of overlap between the occupied and unoccupied 
molecular orbitals. 
A subsequent examination of the energy gap between the HOMO -2 and the LUMO for the 
system revealed, as expected, a slightly larger energy gap as for the previous systems (Table 2), 
suggesting that the reaction would require a larger input of energy in order for cyclisation to take 
place. 
Table 2: Comparison of terminal carbon charges and HOMO/LUMO energy gaps for different 
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2.2 PREPARATION OF SULFUR ANALOGUES 
Due to the success of the synthetic pathway towards the range of oxo-isopsoralens, attention was 
focussed on exploring the feasibility of extending this methodology to incorporate a sulfur 
heteroatom in the isopsoralen ring system. The rationalisation for doing this has already been 
discussed in the introduction, namely that the synthesis of thio-analogues of psoralens have 
found increased application in recent years. Some of these analogues have in fact been shown 
to possess significant biological activity with markedly less phototoxicity when compared to the 
traditionally used oxygenated systems.52,61 
2.2.1 Synthetic pathway towards thio-isopsoralen derivatives 
It was decided that the most feasible way to approach the synthesis of thio-analogues of 
isopsoralen would be to make use of the coumarin parent compound 7-hydroxycoumarin (140), 
which had been used previously and to subsequently convert the phenolic moiety at the 7-
position into a thiol. The thiol group is expected to have similar properties to the phenol, the 7-
thiocoumarin would therefore be expected to undergo nucleophilic attack with an aldehyde, in 
the same manner as observed previously to afford the thio-furan ring system. The question 
arose as to where in the synthetic pathway it would be most advantageous to conduct the 
functional group conversion to the thiol. 
2.2.1.1 The Thio-Claisen rearrangement 
The Thio-Claisen rearrangement68 of allyl phenyl sulfides is different from that observed in the 
oxygen systems. Although the sulfur analogues show high thermal stability, they do undergo 
cleavage at 300°C. However, in solution, preferably in quinoline or diethylaniline, 
rearrangement does occur, but the obtained products are unexpectedly different from the oxygen 
systems. It has been documented in the literature that allyl phenyl sulfide (172) in refluxing 
quinoline is transformed into a mixture of 2-methylthiacoumaran (174) and thiachroman (175) 
(Scheme 48).68 
It has been accepted that o-allylthiophenol (173) is, in fact, the initial product of the 
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rearrangement reaction, but that this product cyclises rapidly under the rearrangement conditions 
into the observed products (174) and (175). It has been shown that the independently prepared 
thiophenol 173 affords the same products in refluxing quinoline.88 The formation of these 
products is thought to be due to the competitive ionic and radical additions of the thiol function 
to the allylic double bond of 173. 
(172) (173) (174) (175) 
40% 37% 
Scheme 48 
It is clear from this information that, in our case, direct conversion to the thiol would not be a 
feasible scenario as the Claisen rearrangement would result in the formation of these undesired 
products. In fact, even conversion to the thiol after rearrangement but prior to ozonolysis would 
not be desirable. It was therefore decided to achieve the conversion to the thiol using the 
reagent, dimethylthiocarbamoyl chloride,53 so as to afford a protected thiol which could then be 
deprotected only after the allyl group had been transformed via reductive ozonolysis. This 
reagent would be advantageous as it would act as both a protecting group and mediator of 
functional group interconversion. Furthermore, the dimethylthiocarbamoyl protecting group is 
stable to ozonolysis. 
2.2.1.2 Synthesis of 1S'-(8-allyl-2-oxo-2//-chromen-7-yl)A îV-dimethylcarbamothioate (177) 
The first two steps in the sequence towards the incorporation of a sulfur atom in the furan ring 
thus involved the reaction of the coumarin 142 with dimethylthiocarbamoyl chloride to afford 
the dimethylcarbamothioate derivative (176). This compound was then subjected to a thermal 
rearrangement reaction, in which there is an interconversion between the sulfur and oxygen 
atoms to give the protected thiol (177) in 86% yield (Scheme 49). It can be seen that use of this 
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(176) (177) 
(i) DMF, NaH; (ii) (CH3)2NCSC1, 60°C; 
(iii) N2, 220-240°C, 40 min. 
Scheme 49 
2.2.1.3 Synthesis of 8-methoxy-8,9-dihydro-2//-thieno[2,3-/z]chromen-2-one (185) 
The successful synthesis of the protected thiol (177) precipitated some thought towards what 
measure should be taken next. Under normal circumstances, in order to generate the thiol, the 
ensuing step would be to cleave off the protecting group by treatment with base and then acid, 
leaving the thiol (178), however, this would presumably undergo rapid cyclisation, as discussed 
earlier in Scheme 47, to afford a mixture of compounds 179 and 180 (Scheme 50), which was 
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It was consequently decided to leave the protected thiol intact until after the aldehyde had been 
generated. The coumarin (177) was therefore subjected to reductive ozonolysis (Scheme 51) to 
afford the aldehyde (181) after workup. This aldehyde, generated in the reaction, was 
subsequently protected as an acetal using the standard procedure,45 and resulted in formation of 
5'-[8-(2,2-dimethoxyethyl)-2-oxo-2//-chromen-7-yl]A';A^-dimethylcarbamothioate (182), which 
was characterised by NMR spectroscopy (Figure 11). The protection step was performed in 
order to prevent any possible reaction of the aldehyde in the basic conditions needed to cleave 
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Figure 11: 500 MHz 'H NMR spectrum of 5-[8-(2,2-dimethoxyethyl)-2-oxo-2//-chromen-7-
yl]ArJV-dimethylcarbamothioate (182) in CDC13. 
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Synthesis of the isopsoralen analogue (185) was then completed by reaction of the acetal (182) 
with KOH, followed by treatment with aqueous acid (Scheme 52). The treatment with acid 
simultaneously cleaved the carbamate group and deprotected the acetal to regenerate the 
aldehyde (183). This compound would presumably undergo rapid nucleophilic attack as was 
seen with the oxygen analogues, resulting in the formation of the hemiacetal (184), this 
intermediate was in fact not isolated. 
This hemiacetal underwent nucleophilic substitution of the hydroxyl group in the presence of 
methanol, affording the desired isopsoralen, 8-methoxy-8,9-dihydro-2//-thieno[2,3-/2]chromen-
2-one (185). This reaction did not proceed as cleanly as with the oxygenated systems, with a 
number of unidentifiable side products being formed, and a significantly lower yield of 29% 






















2.2.1.4 Attempted synthesis of 8-ethoxy-8,9-dihydro-2//-thieno[2,3-/j]chromen-2-one (186) 
This same approach was then attempted using ethanol as a solvent (Scheme 53). This was in 
order to accomplish the synthesis of the ethoxy substituted derivative (186). The synthetic 
procedure was essentially the same, except that in this case there was no protection of the 
aldehyde functionality (181) since this was now thought to be both unnecessary and also a 
possible contributing factor towards the presence of undesirable side products found earlier. 
Unfortunately the approach outlined in Scheme 53 failed to provide any conclusive evidence 
of the desired isopsoralen derivative (186). 
Initial GC-MS analysis of the mixture provided evidence for the presence of the hemiacetal 
derivative (184), but crude NMR spectroscopic analysis failed to provide any additional proof 
due to the presence of some impurities. The only conclusive signals observed were those for the 
four aromatic protons of the coumarin system. Preparative layer chromatography also failed to 
purify the reaction mixture, with NMR spectroscopy of the bands proving to be very similar to 
the original sample. NMR spectrscopic analysis did however show the absence of the 
dimethylcarbamothioate group, which along with the GC-MS data would tentatively suggest that 
the hemiacetal was, in fact, obtained as a major product. 
High resolution mass spectrometry of the sample provided evidence for the presence of the 
charged species (187) (M+, 203), suggesting once again that the hemiacetal was in fact, a major 
component of the original reaction mixture. No explanation could be given for the failure of this 
reaction,* and due to time constraints further attempts at this reaction were not examined. 
Failure was not due to use of the unprotected aldehyde since repetition of the 
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(i) CH3CH2OH, KOH, reflux; (ii) H
+, H20 
Scheme 53 
2.2.2 Variable Temperature NMR Spectroscopic Studies 
An interesting observation was made when studying the proton NMR spectra of compounds 176 
and 177. The signals for the two JV-methyl groups of the dimethylcarbamothioate group of 177 
(Figure 13), which are completely resolved at low temperatures, begin to approach coalescence 
as the temperature is increased to room temperature. The dependance on temperature of these 
rotameric systems is well known and has been extensively documented in the literature.75,89,90'91 
The C-N bond has a high proportion of double bond character [Figure 12 (B)], which hinders 
rotation and subsequently results in the two methyl groups being magnetically non-equivalent. 
At low temperature, the energy of the system is lower than the rotational barrier of the C-N 
double bond, resulting in two separate singlets for the these two methyl groups. 
At higher temperatures, however, the rotational barrier is overcome. Exchange between the two 
methyl groups now occurs at a rate fast enough to cause them to be indistinguishable by NMR 
spectroscopy, resulting in coalescence of the two singlets into one broad signal. 
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CH3
/ C H3 
(A) (B) 
Figure 12 
Figure 13 shows the 500 MHz H NMR signals for the methyl protons of the dimethyl 
carbamothioate group of coumarin derivative 177, in deuterated 1,1,2,2-tetrachloro ethane 
(C2D2C14)
f The NMR signals are recorded at different temperatures, and exhibit the coalescence 
of the two singlets into one broad band as the rate of exchange of the two methyl groups is 
increased with increasing temperature. The coalescence temperature Tc, was found to be 43.0°C 
(316K). 
The free energy of activation for the process, AG* was calculated using the equation:75 
AG* = 2.303 Rrc(log kjjh - log 2.22 Av) 
where R= gas constant 
T= coalescence temperature in K 
kb= Boltzmann's constant 
h= Planck's constant 
A v= difference in chemical shift when signals are completely resolved 
This method equates AG* as 64.3 kJ.mol"1, which is comparable to other reported values90 of 
64-72 kJ.mol"1 for these types of systems. Another reported method by Smith et al.92 for 
determining AG*, making use of Avc, the estimated difference in chemical shift at the 
coalescence point, provided a similar value of 66.5 kJ.mol"1 for AG*. 
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Figure 13: Partial 500 MHz 'H NMR spectra showing the coalescence of the two methyl peaks 
of the dimethylcarbamothioate group of ^(S-allyl^-oxo^/Z-chromen^-yl^iV-
dimethycarbamothioate (177). The coalescence temperature was found to be 316K. 
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The rotameric signals for the dimethylcarbamothioate group for compound 176 show a 
significantly different temperature dependance for the two methyl groups. In this system 
coalescence was only reached at 118°C (391K), over 2.5 times greater than that observed for the 
former system. The corresponding rotational barrier for the process was calculated to be 80.6 
kJ.mol"1, significantly higher than that of the previous system. This indicates that isomer D of 
176 (Figure 14) is much more prevalent than isomer C of 176, i.e. the rotation about the C-N 
bond is significantly more hindered. 
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Another factor to consider for these two systems is the presence of the heteroatom adjacent to 
the carbonyl or thiocarbonyl group. These have a conflicting action, as shown in Figure 15, 
which would affect double bond character of the C-N bond, and would thus also have a lowering 
influence on the rotational barrier of the C-N bond and subsequently on the temperature at 
which coalescence occurs. However, since calculated rotational barriers compare favourably 
with reported values90 for similar systems without the adjacent heteroatom, it can be concluded 
that this effect is minimal. Future work could involve looking at similar systems, but without 
the adjacent heteroatoms, in order to determine to what extent the presence of these atoms 





2.3 SELENIUM ISOPSORALEN ANALOGUES 
Attention was subsequently directed towards utilising the type of chemistry already established 
as a possible route towards the synthesis of some selenium analogues of isopsoralen. As has 
already been mentioned, photobiological52 and other testing (spin trapping and electron spin 
resonance spectroscopy)66 has revealed that some selenium analogues of psoralen are more 
effective than their oxygen analogues in regard to their biological activity. Selenium analogues 
of psoralens thus show great promise in the use of photochemotherapy. However, despite this 
fact very little research has been published on analogues which contain selenium, with only 4 
papers discovered so far detailing the synthesis and study of these types of analogues. There has 
also been no report in the literature on the synthesis of selenium analogues of the angular 
isopsoralens, so any progress made in this regard would obviously be of great importance 
towards the further study of these types of systems. 
2.3.1 Proposed Route to Selenium Isopsoralens 
There has been no report in the literature to date on a method by which an aromatic hydroxyl 
group may be directly converted into a selenyl group. However methods do exist whereby 
bromine can be replaced by selenium in a nucleophilic substitution process, these methods have 
already been used in order to synthesise various selenium analogues of psoralen, as has been 
discussed in the introduction (Section 1.3.2.3). 
Our proposal, outlined in Scheme 54, involved the conversion of the hydroxyl group of 7-
hydroxy-8-allyl coumarin (142) into bromine to afford the 7-bromo derivative (188). This could 
then be subjected to ozonolysis and protection of the aldehyde, as had been previously achieved, 
to afford the acetal (189). The ozonolysis needed to be performed prior to substitution with 
selenium since selenides are known to be oxidised to selenoxides in the presence of ozone.93 The 
acetal (189) could then be reacted with methaneselenol in a similar procedure to that used by 
Jacobs et a/.54-56 to afford the seleno product (190). Deprotection of this and subsequent 
cyclisation between the selenyl residue and the aldehyde, catalysed by polyphosphoric acid silyl 




2.3.1.1 Attempted Preparation of 8-allyl-7-bromo-2#-chromen-2-one (188) 
One of the few methods for converting an aromatic hydroxyl group into a bromine involves the 
use of triphenylphosphine dibromide. This reagent has been successfully used in both aryl and 
aromatic alcoholic systems,94 and a report by Bandin et al.95 describes the conversion of 2,1-
dihydroxynaphthalene (192) into 7-bromo-2-hydroxynaphthalene (193) in 35% yield using this 
approach (Scheme 55). 
(0 
(i) CH3CN, Ph3PBr2 
Scheme 55 
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This procedure was thus attempted in order to convert the coumarin (142) into the bromine 
substituted derivative 8-allyl-7-bromo-2//-chromen-2-one (188) (Scheme 56). However, this 
approach proved unsuccessful, with several attempts resulting only in the regaining of starting 
material with no evidence for the presence of any desired product. 
Due to the failure of triphenylphosphine dibromide in introducing bromine, attention was 
focussed on utilising a triflate in order to bring about the desired transformation. In a recent 
publication, a method was reported in which substitution of an aromatic hydroxyl group with 
a bromide atom was achieved. This method involved the conversion of the hydroxyl to the 
triflate using trifluoromethanesulfonic anhydride, followed by treatment with 
tetrabutylammonium bromide. This method has been used successfully by Makosza and Podraza 
in hydroxyazulene systems96 (Scheme 57), with the 6-hydroxyazulene derivative 194 being 
converted into the triflate (195) in high yield. Subsequent reaction with various alkyl ammonium 
halides afforded the substituted azulene derivatives (196) in ca. 90% yields. 





Unfortunately, this method also proved unsuccessful when attempted on our coumarin system 
(Scheme 58). The initial reaction did afford the triflate (197) as expected, but subsequent 
treatment with Bu4NBr failed to produce the expected bromide (188), with only the starting 
triflate being isolated from the reaction mixture after several attempts at the reaction. 
(142) 
(0 
CF 3S0 20 
(H) 
(197) (188) 
(i) THF, (CF3S02)20, Et3N,-70°C; 
(ii) Acetonitrile, Bi^NBr, reflux 
Scheme 58 
2.3.2 Revised Synthetic Route 
The lack of success in synthesising the coumarin 188 led to a new proposed synthetic route 
utilising bromophenol (198) as a potential starting point. AUylation and Claisen rearrangement 
of this compound should afford the phenol (200a), along with its other ortfzo-rearranged product 
as outlined in Scheme 59. The desired phenol, once isolated, could then be converted into the 
corresponding coumarin (201) via the Pechmann Condensation Reaction.97 Once the substituted 
coumarin 200 had been prepared, subsequent substitution with selenium, ozonolysis and 
cyclisation could be achieved as previously discussed in Scheme 54 (see page 71). 
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Bf OH Br O 
(198) (199) (200a) (201) 
Scheme 59 
(202) 
2.3.2.1 Synthesis of 2-allyl-3-bromophenol (200a) 
The first step in the new proposed synthetic route (Scheme 60) involved the allylation of 
bromophenol using the same procedure as had previously been performed during the earlier 
synthesis of 7-allyloxy coumarin (141). This afforded the allyl phenyl ether (199) which, upon 
Claisen rearrangement gave the two expected regioismers, 2-allyl-3-bromophenol (200a) and 
2-allyl-5-bromophenol (200b). These were then separated using column chromatography. 







(i) K2CO3, allylbromide, acetone, reflux; 
(ii) N2, 220°C, 40min. 
Scheme 60 
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Separation of the two isomers was difficult due to the similar retention times of the two on silica 
gel, but separation was achieved using a relatively non-polar solvent system (5:95 ethyl 
acetate/hexane) to give the two isomers in a ratio of 53% of (200a) to 41% of (200b). This ratio 
differs somewhat from those obtained by White and Slater,98 who determined experimentally 
a yield of ca. 36% for (200a) and a ratio of 0.56 for the two isomers. 
2.3.2.2 Attempted Synthesis of Coumarin System via Pechmann Condensation 
Once the desired regioisomer had been isolated, the preparation of the coumarin ring system was 
attempted using the well known Pechmann Condensation reaction.97 This reaction, widely used 
for the synthesis of coumarin systems, generally involves the coupling of a P-ketoester with a 
phenol (Scheme 61) to give access to a variety of 4-substituted coumarins. In this project, using 
2-allyl-3-bromophenol (200a), this reaction should afford the desired coumarin (201). The 
advantage of using this reaction is, of course, the possibility of accessing extra functionality at 










The first attempt at the Pechmann Condensation proposed the use of ethylacetoacetate as the P-
ketoester, which should have led to the formation of the equivalent 4-methyl substituted 
coumarin derivative (201, R=CH3). This reaction was repeatedly attempted using three different 
catalysts: concentrated sulfuric acid, aluminium trichloride and phosphoric acid. All these are 
known condensing agents for the Pechmann reaction and have been used successfully in 
different systems, however all three failed to induce the Pechmann Condensation to occur, with 
GC-MS and NMR analysis of the reaction mixtures revealing the presence of starting material 
only. It was then decided to utilise another approach which had been reported for the synthesis 
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of the 4-hydroxycoumarin derivative (203). The method (Scheme 62) involves the use of 
malonic acid, with an equimolar mixture of anhydrous zinc chloride and phosphorous 
oxychloride as the condensing agents." However, this approach also proved unsuccessful and 









/ * O 
(203) 
(i) ZnCl2, POCl3, 65°C, 35hrs. 
Scheme 62 
2.3.2.3 Attempted synthesis of the selenium substituted benzofuran ring 
Due to the lack of success with the formation of the benzopyran ring system, and time 
constraints, it was decided to focus attention on one key aspect, namely the inclusion of 
selenium into the furan ring. Once this had been achieved one could then look at the 
construction of the benzopyran ring. To this end it was proposed to protect the hydroxyl group 
of 200a with a suitable protecting group and proceed with the rest of the synthesis of the 
benzofuran system. 
The 2-allyl-3-bromophenol (200a) was thus reacted with ter/-butyldimethylsilyl chloride,100 a 
versatile protecting agent for the hydroxyl group, (Scheme 63) to afford the protected phenol 
(204).This compound, upon treatment with ozone followed by reductive workup, and 
subsequent protection of the aldehyde, afforded the acetal, [3-bromo-2-(2,2-









B f ^ ^ O T B D M S 
C H 3 0 - ^ 
OCH3 (205) 
(i) THF, NaH, (CH3)3C(CH3)2SiCl; 
(ii) THF, 03) -78°C, then dimethylsulfide, -10°C to R.T.; 
(iii) CH3OH, p-TSA, 4A molecular sieve, reflux 
Scheme 63 
Following the successful synthesis of the acetal (205), the nucleophilic subtitution of the 
bromine atom with methaneselenol was attempted in order to synthesise the seleno-ether (206), 
and thereby introduce the selenium residue into the correct position for the synthesis of the 
desired seleno-isopsoralen derivative (Scheme 64). However, this reaction was unsuccessful, 
GC-MS and NMR analysis of the products obtained suggest that instead of the nucleophilic 
substitution of the bromine atom taking place, the methaneselenol deprotected the silyl group 












(i) K2C03, acetonitrile, methaneselenol 
Scheme 64 
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Lack of success with this prompted looking at the original bromophenol (200a) and determining 
if just the substitution was in fact possible before any of the other synthetic work had been 
achieved on this compound. The reaction was attempted using two separate methods in order 
to prepare the substituted phenol (207). Both methaneselenol and lithium methyl selenide101102 
(which should hopefully act as a more powerful nucleophile) were used in order to induce the 
substitution of the bromine (Scheme 65), but both these approaches failed and only starting 
material was isolated from both these reaction mixtures. 
^ N 
^ ^ 






(i) K2CO3, acetonitrile, methaneselenol 
(ii) MeSeLi 
Scheme 65 
The synthetic work attempted towards the range of selenium analogues of ispsoralen proved 
unsuccessful in synthesising these types of compounds. However, it is still judged that this is 
a highly feasible area of research and therefore should not be discontinued without further 
endeavours. The following argument provides a feasible explanation for the lack of success in 
this area, and also attempts to put forward ideas towards the successful synthesis of selenium 
analogues of isopsoralen. The novelty of this work demands that this area of research be 
continued. 
A possible reason for the failure of all attempts to substitute the bromine atom with a selenyl 
group can be found when looking at the systems used in this project. The selenyl group is 
coming in as a nucleophile. However, the benzene ring of, for example, 200a is already electron 
rich, which would hinder any nucleophilic substitution from taking place. Added to this is the 
fact the aromatic ring contains two groups, a phenol and an allyl chain, which are both, 
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themselves, electron donating. This would subsequently make the aromatic ring even more 
electron rich, further diminishing the chance of any nucleophilic substitution taking place. 
In order to induce nucleophilic substitution, we therefore need to pull electron density out of the 
aromatic ring using suitable groups. One such compound is 4,6-dibromoisophthalaldehyde (92), 
which has been used successfully by Jacobs et a/54'56 when substituting bromine with selenium. 
This compound, as was shown in the introduction, has been utilised as a starting material in the 
synthesis of a number of selenium analogues of psoralen (see Schemes 26 to 30, pages 30 to 
34). The difference in this compound is, of course, the presence of two aldehyde substituents. 
These aldehydes are electron withdrawing, and would therefore pull electron density out of the 
phenyl ring. This has the effect of making the phenyl ring less electron rich, and thereby 
facilitating the nucleophilic substitution process. 
Future work on this project would therefore make use of this or similar compounds as a means 
to the preparation of selenium-substituted isopsoralen analogues. The proposed approach 
towards this synthesis is outlined in Schemes 66 and 67. Starting with 4,6-
dibromoisophthalaldehyde (92), and converting one of the bromine atoms into ahydroxyl group 
would afford the phenol derivative (97). This phenol could then be subjected to the usual 
treatment carried out in this project. Allylation of the hydroxyl group would afford the allyl aryl 
ether (208), which at this stage could be reaction with methaneselenol to give the substituted 
derivative 4-(allyloxy)-6-(methylselenyl) isophthalaldehyde (209). A recently discovered report 
by Clive and Postema103 describe conditions whereby ozonolysis can be performed on olefinic 
phenyl selenides with preservation of the selenium unit, thus substitution with selenium before 
attempting ozonolysis is proposed. Claisen rearrangement of 209 would then afford the 
rearranged product (210). Another option would be to do the Claisen rearrangement first before 
attempting the nucleophilic substitution. 
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Once the phenol (210) is obtained, the synthesis of the selenium substituted furan ring can be 
attempted (Scheme 67). First the hydroxyl group needs to be protect as before, by reaction with 
tert-butyl dimethylsilylchloride to afford the protect phenol (211). This, after ozonolysis and 
reduction to the aldehyde (212), could then be cyclised in the presence of polyphosphoric acid 
silyl ether (PPSE) to give the selenofuran (213). Synthesis of the pyrone ring using known 
procedures would then afford the seleno-isopsoralen 2-oxo-2//-seleno[2,3-fr|chromene-6-
carbaldehyde (214). 
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If successful, this procedure could hopefully be further modified in an effort to lead to a diverse 
range of other seleno-isopsoralen derivatives. Some possibilities include modification of the 
aldehyde functionality of 214, and extension of this approach to include selenium or sulfur in 
place of the oxygen atom in the pyrone ring. 
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2.4 CONCLUSION 
The initial aims of this project, to develop a synthetic approach towards a range of new 
isopsoralen derivatives, and to extend this approach to include sulfur in place of oxygen in the 
benzofuran ring, have all been achieved. 
The synthesis of a range of 8-alkyl substituted 8,9-dihydro-2//-furo[2,3-/z]chromen-2-ones in 
good yields was achieved, utilising the reductive ozonolysis of o-allyl hydroxycoumarins as a 
key synthetic step. A computational examination of the coumarin systems studied have led to 
a better understanding for the regioselectivity observed for the Claisen rearrangement. Extension 
of this approach to include sulfur led to the synthesis of the thio-isopsoralen derivative, 8-
methoxy-8,9-dihydro-2//-thieno[2,3-/j]chromen-2-one, via conversion of the hydroxyl group 
into a thiol using the known reagent dimethylthiocarbamoyl chloride. An intriguing 'H NMR 
spectroscopic study was also performed on the JV.jV-dimethylcarbamothioate moiety of the 
protected thiol. 
A further aim of this project was to develop a synthetic route which would provide access 
towards isopsoralen derivatives containing selenium in the benzofuran ring system. Initial 
investigations in this regard have indicated great potential for this type of approach, and have 
laid the foundations for the future synthesis of seleno-isopsoralen derivatives. 
This project has thus identified various possibilities for future research; these include the 
following :-
(i) use of more highly substituted allyl groups as a means of accessing further 
substituted isopsoralen derivatives, 
(ii) a more complete computational study towards understanding the regioselectivity of 
the Claisen reaction, using the variously substituted allyl groups, 
(iii) work towards the synthesis of additional substituted thio-isopsoralen analogues, 
(iv) a more complete NMR spectroscopy study of the N, JV-dimethylcarbamothioate 
groups, with or without heteroatoms adjacent to the carbonyl or thiocarbonyl 
group. 
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All 'H, 13C and 2D NMR spectra were run on a Varian Unity-Inova 500 MHz spectrometer, and 
were referenced using the solvent signals. Spectra recorded in CDC13 were calibrated using the 
solvent signal at 7.26 ppm for 'H and 77.0 ppm for 13C, while 'H and 13C spectra run in CD3OD 
were calibrated using the solvent signals. All coupling constants (J) are given in Hz, and the atom 
numbering used in quoting the NMR data follows IUPAC nomenclature. 104105Low resolution 
mass spectra were recorded on a Hewlett Packard 5890 using a quadrupole mass analyzer, while 
high resolution mass spectra were obtained on a double-focusing Kratos MS 80RF mass 
spectrometer (Cape Technikon Mass Spectrometry Unit). Melting points were determined on a 
Kofler hot stage apparatus and are uncorrected. 
All solvents used were distilled and dried prior to use.106 When reactions were carried out using 
air- or moisture-sensitive reagents, such as NaH, triflic anhydride, methyllithium, phosphorus 
reagents and ethyl malonyl chloride, the glassware was flame dried under dry nitrogen 
(previously flushed through a 3 A molecular sieve drying column) before use. All other reactions 
were carried out using semi-dry conditions i.e. using oven-dried glassware under an inert (dry 
nitrogen) atmosphere. Anhydrous solvents were obtained as follows: 
(i) THF (tetrahydrofuran) was dried by boiling under reflux over sodium wire, in the presence 
of benzophenone, then distilled, 
(ii) Xylene and triethylamine (Et3N) were boiled under reflux over CaH2, distilled and 
collected over 3A molecular sieves, 
(iii) Methanol and ethanol were boiled under reflux over calcium carbonate, then distilled, 
(iv) Acetone was dried by storing over 4A molecular sieve overnight, 
(v) Dimethylformamide (DMF) was dried by boiling under reflux over 4A molecular sieve,107 
then distilled and collected over 4A molecular sieve. 
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Flash chromatography was performed using either column chromatography with Merck silica gel 
60 (230-400 mesh; particle size 0.040-0.063 nm) or by radial chromatography on a chromatotron 
using Merck silica gel 60 PF264 containing gypsum for Preparative Layer Chromatography. Thin 
Layer Chromatography (TLC) was performed on Merck Aluminium Sheets containing Silica Gel 
60 F254 (layer thickness, 0.2 mm), with visualization of the compounds by inspection under UV 
light (254/365 nm) and/or by exposure to iodine vapour. 
Ozone required for the ozonolysis reactions was generated using a Fischer Ozone Generator 
(Model 500), with a current setting of ca. 200mA and a flow rate of ca. 1 ml/min. 
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3.2 PREPARATIVE PROCEDURES 
3.2.1 Synthetic work towards oxygen analogues 
Preparation of 7-(allyloxy)-2//-chromen-2-one (141) 
3-bromo-l-propene (5.71 ml, 66 mmol) was added dropwise under dry nitrogen, using a pressure 
equalising dropping funnel, to a stirred mixture of 7-hydroxy-2//-chromen-2-one (140) (5.0 g, 
30 mmol) and anhydrous K2C03 (5.8 g, 41 mmol) in dry acetone (ca. 150 ml).The resulting 
mixture was then boiled under reflux for 5 hours, following which it was allowed to cool, and 
the K2C03 filtered off using a sintered glass funnel. The filtrate and washings were removed in 
vacuo and the residue recrystallised from methanol to afford, as pale yellow crystals, 7-
(allyloxy)-2//-chromen-2-one (141) (5.62 g, 92%), m.p. 78-79°C (from methanol) (lit.,24 93-
93.5°C); v^KBrycm-1 1614, 1723 and 3082; 8H(500 MHz; CDC13) 4.60 (2H, d, JV2, 5.3, 1'-
CH2), 5.34 (1H, dd, JC1S 10.4 and Jgem 1.2, C=CH) and 5.44 (1H, dd, 7^17.2 and Jgem 1.2, C=Ctf), 
6.05 (1H, ddt, Jttans 17.3, Jcis 10.5 and J2.,, 5.3,2'-H), 6.26 (1H, d, J34 9.5, 3-H), 6.83 (1H, d,J86 
2.3,8-H), 6.87 (1H, dd, J6%2.3 and J65 8.5,6-H), 7.38(1H, d, J5fi 8.6, 5-H) and 7.64 (1H, d, J43 
9.3,4-H); 6C(125 MHz; CDC13) 69.9 (C-l'), 102.4 (C-8), 113.2 (C-4a), 113.80 (C-3), 113.86 (C-
6), 119.2(C-3'), 129.4 (C-5), 132.8 (C-2'), 114.0 (C-4), 156.5 (C-8a), 161.8 (C-7) and 162.4 (C-
2); m/z 202 (M+, 100%) and 187 (71). 
Preparation of 8-alIyl-7-hydroxy-2//-chromen-2-one (142) 
7-(allyloxy)-2//-chromen-2-one (141) (5.0 g, 24.7 mmol) was dissolved in JV, JV-diethylaniline 
(ca. 50 ml) in a two-necked flask attached to a nitrogen line and a condenser, and boiled under 
reflux at ca. 220 °C for 3 hours. The reaction mixture was then cooled, during which time 
precipitation of some of the product occurred, hexane (40 ml) was then added in order to 
precipitate out the remaining product. The precipitate was filtered, washed with hexane, dried 
by vacuum filtration, and recrystallised from ethyl acetate to afford, as cream crystals, 8-allyl-7-
hydroxy-2#-chromen-2-one (142) (4.2 g, 84%), m.p. 151 -153°C (from ethyl acetate) (lit.,24165-
166°C); v^KBrycm"11600,1699 and3332; 8H(500 MHz; CDC13) 2.81 (lH,s,OH),3.61 (2H, 
d,J,,2,6.2, l'-CH2),5.0(lH,dd,ycis 10.1 and./gem 1.8,C=CH)and5.12(lH,dd, J ^ 17.2andJgem 
1.8, C=CH), 6.01 (1H, ddt, Jtrans 17.2, Jcis 10.1 a n d ^ . 6.2,2'-H), 6.20 (1H, d, J34 9.6,3-H), 6.80 
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(1H, d, J6J5 8.5, 6-H), 7.21 (1H, d, J5fi 8.5, 5-H) and 7.64 (1H, d, J43 9.4, 4-H); 8C(125 MHz; 
CDC13) 27.3 (C-l'), 112.2 (C-3), 112.7 (C-4a), 113.2 (C-6), 114.7 (C-8), 115.9 (C-3'), 127.2 (C-
5), 135.69 (C-2'), 145.1 (C-4), 154.2 (C-8a), 159.5 (C-7) and 162.9 (C-2); m/z 202 (M+, 100%), 
187(75), 173 (28) and 159 (26). 
Preparation of 8-methoxy-8,9-dihydro-2//-furo[2,3-^]chromen-2-one (150a) 
8-allyl-7-hydroxy-2//-chromen-2-one (142) (2.0 g, 9.9 mmol) was dissolved in dry THF (60 ml) 
in a three-necked flask fitted with a reflux condenser and attached to an ozone generator. Two 
traps containing an acidified 1.1 M KI solution (110 ml acidified with 10 ml glacial acetic acid) 
were connected to the outlet of the three-necked flask in order to mop up any unreacted ozone. 
The flask was cooled to -78°C using a solid C02/acetone bath. Ozone was then bubbled through 
the stirred mixture for 100 minutes at a rate of ca. 1 ml/min, after which analysis by TLC showed 
the disappearance of starting material. Dimethyl sulfide (0.9 ml, 12.4 mmol) was added, the 
reaction mixture warmed to -10°C (salt/ice bath), and stirred for a further 3 hours, allowing the 
mixture to slowly warm to room temperature. Methanol (30 ml) was then added, and the mixture 
was boiled under reflux for 3 hours and left stirring overnight under nitrogen. The solvent was 
then removed in vacuo to leave a dark orange oil, from which the product crystallized out as 
orange crystals. Recrystallisation from methanol afforded 8-methoxy-8,9-dihydro-2H-furo[2,3-
h]chromen-2-one (150a) (1.43 g, 66%), m.p. 144-145°C (from methanol) (Found: M+, 
218.05846. C12H10O4 requires M, 218.05791); vmax(KBr)/cm-' 1615, 1724 and 3442; 6H(500 
MHz; CDCI3) 3.24 (1H, dd, Jgem 17.1 and J9M 2.3, 9-CHJ and 3.45 (1H, dd, Jgem 17.1 and J9bg 
6.6, 9-CHb), 3.56 (3H, s, CH3), 5.80 (1H, dd, J89a2.3 and J89b 6.6, 8-H), 6.22 (1H, d, J34 9.6,3-
H), 6.81 (1H, d, J65 8.2, 6-H), 7.30 (1H, d, J56 8.2, 5-H) and 7.64 (1H, d, J43 9.5,4-H);5C(125 
MHz; CDC13) 34.3 (9-CH2), 56.9 (l'-CH3), 107.9 (C-6), 109.7 (C-8), 113.08 (C-9a), 113.2 (C-3), 
114.05 (C-4a), 129.4 (C-5), 144.9 (C-4), 151.9 (C-9b), 161.7 (C-6a) and 162.9 (C-2); m/z 218 
(M+, 100%), 187 (60), 175 (43) and 147 (22). 
Preparation of 8-ethoxy-8,9-dihydro-2#-furo[2,3-/i]chronien-2-one (150b) 
Following the procedure used for the synthesis of 8-methoxy-8,9-dihydro-2//-furo[2,3-/z] 
chromen-2-one (150a), 8-allyl-7-hydroxy-2//-chromen-2-one (142) (0.80 g, 3.96 mmol) was 
dissolved in dry THF (40 ml) in a three-necked flask, cooled to -78°C, and ozone was bubbled 
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through the system for ca. 80 minutes. Dimethyl sulfide (0.4 ml, 5.5 mmol) was then added, and 
following workup of the reaction afforded 8-ethoxy-8,9-dihydro-2H-furo[2,3-h]chromen-2-one 
(150b), as pale yellow crystals, (0.62 g, 67%), m.p. 107-109°C (from ethanol) (Found: M+ 
232.07441, C13H1204 requires M, 232.07356); vmax(KBr)/cm-' 1613, 1726 and 3320; 6H(500 
MHz; CDC13) 1.26 (3H, t, J2.,, 7.1,2*-CH3), 3.23 (1H, dd, Jgem 16.9 and J9a8 2.5,9-CHJ and 3.45 
(1H, dd, Jgem 16.9and J9M 6.7, 9-CHb), 3.69 and 3.95 (2H, 2xdq, Jgem 9.4 and JYJ 7.1, 1*-CH2), 
5.91 (1H, dd, J89a 2.5 and </89b 6.6, 8-H), 6.21 (1H, d, J34 9.4, 3-H), 6.79 (1H, d, J65 8.2, 6-H), 
7.29 (1H, d, J56 8.2, 5-H) and 7.64 (1H, d, J43 9.4, 4-H); 6C(125 MHz; CDC13) 15.7 ( 2'-CH3), 
34.4 (9-CH2), 65.5 (l'-CH2), 107.9 (C-6), 108.7 (C-8), 113.08 (C-3), 113.1 (C-9a), 113.9 (C-4a), 
129.4 (C-5), 144.7(C-4),151.9(C-9b), 161.7 (C-6a) and 162.8 (C-2); m/z 232 (M+, 79%), 175 
(100), 148 (25) and 187 (20). 
Preparation of 8-isopropoxy-8,9-dihydro-2//-furo[2,3-^]chromen-2-one (150c) 
Following the procedure used for the synthesis of 8-methoxy-8,9-dihydro-2/f-furo[2,3-/z] 
chromen-2-one (150a), 8-aHyl-7-hydroxy-2//-chromen-2-one (142) (0.80 g, 3.96 mmol) was 
dissolved in dry THF (40 ml) in a three-necked flask, cooled to -78°C, and ozone was bubbled 
through the system for ca. 80 minutes. Dimethyl sulfide (0.4 ml, 5.5 mmol) was then added, and 
following workup of the reaction afforded 8-isopropoxy-8,9-dihydro-2H-furo[2,3-h]chromen-2-
one (150c), as an orange oil from which the product crystallised out as pale yellow crystals, (0.73 
g, 75%), m.p. 117-119°C (from isopropanol) (Found: M+ 246.08952, C14H1404 requires M, 
246.08921); v^KBrycrn 1 1625,1715 and 3419; 8H(500 MHz; CDC13) 1.20-1.25 [6H, 2xd, J 
6.1, CH(C#3)2], 3.23(lH,dd,Jgem 16.9andJ9M2.4,9-CHa)and3.45(lH,dd,Jgem 16.9and J9b8 
6.9,9-CHb), 4.08 (1H, heptet, J6.2, l'-H), 6.01 (1H, dd, J89a2.5 and J89b 6.9, 8-H), 6.23 (1H, d, 
J3 4 9.4,3-H), 6.79 (1H, d, J65 8.2,6-H), 7.29 (1H, d, J56 8.1,5-H) and 7.64 (1H, d, J43 9.4,4-H); 
6C(125 MHz; CDC13) 22.0 and 23.6 [CH(CH3)2], 34.2 (9-CH2), 71.8 (C-1'), 106.2 (C-8), 107.4 
(C-6), 107.6 (C-4a), 112.5 (C-3), 112.8 (C-9a), 128.9 (C-5), 144.3 (C-4), 151.6 (C-9b), 160.8 (C-
6a) and 162.4 (C-2); m/z 246 (M+, 53%), 204 (44) and 175 (100). 
Preparation of 8-(tert-butoxy)-8,9-dihydro-2/T-furo[2,3-/i]chromen-2-one (150d) 
Following the procedure used for the synthesis of 8-methoxy-8,9-dihydro-2/f-furo[2,3-ft] 
chromen-2-one (150a), 8-allyl-7-hydroxy-2#-chromen-2-one (142) (0.80 g, 3.96 mmol) was 
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dissolved in dry THF (40 ml) in a three-necked flask, cooled to -78°C, and ozone was bubbled 
through the system for ca. 80 minutes. Dimethyl sulfide (0.4 ml, 5.5 mmol) was then added, and 
following workup of the reaction afforded 8-(tert-butoxy)-8,9-dihydro-2H-furo[2,3-hJchromen-
2-one (150d), as an orange oil from which the product crystallised out as yellowish crystals, (0.74 
g, 71%), m.p. 119-122°C (fromtert-butanol) (Found: M+-C(CH3)3 204.04375, C15H1604requires 
M, 260.104859); vmax(KBr)/cm-' 1621, 1729 and 3385; 5H(500 MHz; CDC13) 1.25 [9H, s, 
C(CH3)3], 3.24 (1H, dd, Jgem 17.0 and J9ag 2.3, 9-CHJ and 3.43 (1H, dd, Jgem 17.1 and J9b8 6.6, 
9-CHb), 5.79 (1H, dd, J89a2.3 and./8>9b 6.6, 8-H), 6.21 (1H, d, J34 9.6,3-H), 6.80 (1H, d, J65 8.2, 
6-H), 7.29 (1H, d, J56 8.2, 5-H) and 7.64 (1H, d, J43 9.4, 4-H); 6C(125 MHz; CDC13) 29.9 
[C(CH3)3], 33.8 (9-CH2), 102.7 (C-l'), 107.5 (C-6), 109.3 (C-8), 112.7 (C-3), 113.6 (C-4a), 125.1 
(C-9a), 129.0 (C-5), 144.3 (C-4), 151.5 (C-9b), 161.3 (C-6a) and 162.3 (C-2); m/z 260 (M+, 
16%), 176 (100), 204 (67) and 148 (28). 
Preparation of 8-hydroxy-8,9-dihydro-2//-furo[2,3-^]chromen-2-one (149) 
8-allyl-7-hydroxy-2//-chromen-2-one (142) (1.0 g, 4.95 mmol) was dissolved in dry THF (40 ml) 
in a three-necked flask which was connected to an ozone generator. Two KI traps (acidified 1.1 
M solution) were also connected to the three-necked flask in order to neutralize any unreacted 
ozone. The reaction mixture was then cooled to -78°C, and ozone was bubbled through the 
system for ca. 80 minutes. Dimethyl sulfide (0.45 ml, 6.2 mmol) was then added, the reaction 
mixture warmed to -10°C (salt/ice bath) and stirred overnight, allowing the mixture to warm to 
room temperature. The solvent was then removed in vacuo and the resulting residue was passed 
through a column (50:50 ethyl acetate/hexane as a running solvent) to afford, as white crystals, 
8-hydroxy-8,9-dihydro-2#-furo[2,3-/z]chromen-2-one (149) (0.52 g, 51%), m.p. 137-139 °C 
(from ethyl acetate) (Found: M+, 204.0426, CnH804 requires M, 204.04226); Vmax(KBr)/cm-
1 
1614,1689 and 3302; 8H(500 MHz; CD3OD)'3.19 (2H, d, J98 5.3,9-CH2), 4.89 (1H, t, J89 5.2, 
8-H), 6.21 (1H, d, J3A 9.4, 3-H), 6.88 (1H, d, J65 8.5, 6-H), 7.31 (1H, d, J5fi 8.5, 5-H) and 7.78 
(1H, d, J4i3 9.4,4-H); 8C(125 MHz; CD3OD) 30.9 (9-CH2), 98.2 (C-8), 111.5 (C-3), 111.9 (C-4a), 
112.7 (C-9a), 113.8 (C-6), 127.7 (C-5), 145.9 (C-4), 154.4 (C-9b), 160.5 (C-6a) and 163.5 (C-2); 
m/z 204 (M+, 34%), 174 (100), 146 (75) and 118 (29). 
'OH signal suppressed due to 2D exchange. 
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Preparation of 2//-furo[2,3-/i]chromen-2-oiie (156) 
8-hydroxy-8,9-dihydro-2//-furo[2,3-/z]chromen-2-one (149) (0.03 g, 0.15 mmol) was placed in 
a two-necked flask containing THF (20 ml) and connected to a reflux condenser and a nitrogen 
line. p-Toluenesulfonic acid (0.01 g) and some 3A molecular sieve were added to the flask and 
the reaction mixture was boiled under reflux for 2 hours. The mixture was then passed through 
a plug of silica gel to remove the catalyst, and the solvent removed in vacuo to afford, as 
colourless crystals, 2/f-furo[2,3-/2]chromen-2-one (156) (0.028 g, 100%), m.p. 132-133 °C(from 
methanol) (lit.,33 137-137.5°C); vmax(KBr)/cm-' 1620, 1709 and 3385; 6H(500 MHz; CD3OD) 
6.35 (1H, d, J34 9.4, 3-H), 6.59 (1H, d, J9fi 2.2, 9-H), 6.98 (1H, d, J^ 2.1, 8-H), 7.21 (1H, d, J5fi 
8.3, 5-H), 7.39 (1H, d, J65 8.3,6-H) and 8.06 (1H, d,/4>3 9.5,4-H); 8C(125 MHz; CD3OD) 98.4 
(C-9), 106.8 (C-6), 113.2 (C-3), 114.1 (C-4a), 117.6 (C-9a), 125.2 (C-5), 146.1 (C-4), 146.2 (C-
8), 147.9 (C-9b), 156.8 (C-6a) and 161.2 (C-2); m/z 186 (M+, 100%), 158 (94) and 102 (28). 
Preparation of 7-[(2-methyl-2-propenyl)oxy]-2/7-chromen-2-one (157) 
3-bromo-2-methyl-l-propene§ (5.0 ml, 49.6 mmol) was added dropwise under nitrogen to a 
stirred mixture of 7-hydroxy-2//-chromen-2-one (140) (4.02 g, 24.3 mmol) and K2C03 (4.66 g, 
32.9 mmol) in dry acetone (ca. 130 ml). The mixture was then boiled under reflux for 5 hours, 
allowed to cool, and the K2C03 filtered and washed with fresh acetone. The solvent was then 
removed in vacuo and the residue recrystallised from methanol to afford 7-[(2-methyl-2-
propenyl)oxy]-2//-chromen-2-one (157), as cream crystals (4.55 g, 86%), m.p. 59-60°C (from 
methanol); v^KBrycrn1 1609,1734 and 3454; 6H(500 MHz; CDC13) 1.82 (3H, s, CH3), 4.49 
(2H, s, T-CH2), 5.02 and 5.09 (2H, 2*s, 3'-CH2), 6.24 (1H, d, J34 9.6, 3-H), 6.81 (1H, d, JS6 2.4, 
8-H), 6.86 (1H, d, J65 8.7 and J6S 2.3, 6-H), 7.36 (1H, d, J56 8.7, 5-H) and 7.63 (1H, d, 743 9.4, 
4-H); 6C(125 MHz; CDC13) 19.9 (CH3), 72.9 (l'-CH2), 102.4 (C-8), 113.3 (C-4a), 113.7 (C-6), 
113.8 (C-3), 114.2 (3'-CH2), 129.4 (C-5), 140.4 (C-2'), 144.1 (C-4), 156.5 (C-8a), 161.9 (C-7) 
and 162.6 (C-2); m/z 216 (M+, 100%), 201 (61) and 134 (37). 
§3-chloro-2-methyl-l-propene (3.60 g, 40 mmol) was also used, affording the required 
product 7-[(2-methyl-2-propenyl)oxy]-2#-chromen-2-one (157) (4.21 g, 80%). 
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Preparation of 7-hydroxy-8-(2-methyl-2-propenyl)-2/f-chromen-2-one (158) 
7-[(2-methyl-2-propenyl)oxy]-2/f-chromen-2-one (157) (3.80 g, 17.6 mmol) was dissolved in 
N, Af-diethylaniline (40 ml) in a one-necked flask fitted with a reflux condenser and nitrogen line, 
and boiled under reflux for 3 hours. The reaction mixture was then left to cool and hexane (ca.40 
ml) was added to precipitate out the product, which was then recrystallized from ethyl acetate to 
afford 7-hydroxy-8-(2-methyl-2-propenyl)-2//-chromen-2-one (158), as cream crystals (2.95 g, 
77%), m.p. 123-125°C (from ethyl acetate); Vmax(KBr)/cm-' 1603,1684 and 3442; 5H(500 MHz; 
CDC13) 1.77 (3H, s, CH3), 3.64 (2H, s, l'-CH2), 4.81 and 4.90 (2H, 2xs, 3*-CH2), 6.25 (1H, d,J34 
9.4,3-H), 6.56 (1H, br. s, OH), 8.86 (1H, d, J6 5 8.5,6-H), 7.27 (1H, d, J56 8.5,5-H) and 7.66 (1H, 
d, J43 9.6, 4-H); 6C(125 MHz; CDC13) 22.5 (CH3), 31.4 (l'-CH2), 112.5 (3*-CH2), 112.6 (C-3), 
112.8 (C-4a), 113.2 (C-8), 113.5 (C-6), 127.4 (C-5), 143.6 (C-2')> 144.6 (C-4), 153.7 (C-8a), 
159.1 (C-7) and 162.1 (C-2); m/z 216 (M+, 87%), 201 (100) and 173 (48). 
Preparation of 7-hydroxy-8-(2-oxopropyl)-2fir-chromen-2-one (159) 
7-hydroxy-8-(2-methyl-2-propenyl)-2/f-chromen-2-one (158) (0.8 g, 3.7 mmol) was dissolved 
in methanol (40 ml) in a three-necked flask, cooled to -78°C (solid C02/acetone) and ozone was 
passed through the system for ca. 80 minutes. Dimethyl sulfide (0.33 ml, 4.57 mmol) was then 
added and the reaction mixture stirred overnight under nitrogen while allowing to gradually warm 
to room temperature. The solvent was removed in vacuo to leave an orange oil from which the 
final product crystallised out. Recrystallisation from methanol afforded 7-hydroxy-8-(2-
oxopropyl)-2//-chromen-2-one (159), as pale orange crystals (0.56 g, 68%), m.p. 188-190°C 
(from methanol) (Found: M+, 218.05768, C12H10O4 requires M, 218.05791); vmax(KBr)/cm-' 
1614, 1729 and 3317; 5H(500 MHz; CD3OD)
# 2.29 (3H, s, 3'-CH3), 3.99 (2H, s, l'-CH2), 6.19 
(1H, d, J34 9.4, 3-H), 6.85 (1H, d, J65 8.5, 6-H), 7.33 (1H, d, J5fi 8.5, 5-H) and 7.75 (1H, d, J43 
9.4,4-H); 5C(125 MHz; CD3OD) 29.4 (3*-CH3), 37.8 (2'-CH2), 109.5 (C-8), 111.3 (C-3), 112 (C-
4a), 112.6 (C-6), 127.9 (C-5), 145.2 (C-4), 153.8 (C-8a), 159.9 (C-2), 162.7 (C-7) and 207.5 (C-
2'); m/z 218 (M+, 100%) and 187 (52). 
OH signal suppressed due to 2D exchange. 
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Preparation of 8-methyl-2Z/-furo[2,3-^]chromen-2-one (162) 
A mixture of 7-hydroxy-8-(2-oxopropyl)-2//-chromen-2-one (159) (0.25 g, 1.25 mmol), andp-
toluenesulfonic acid (0.05 g) in dry toluene (20 ml) was placed in a two-necked flask fitted with 
a Dean and Stark apparatus containing 4A molecular sieve, and connected to a nitrogen line. The 
mixture was then boiled under reflux for 4 hours, cooled, and then passed through a plug of silica 
gel. Removal of the solvent in vacuo afforded, as white crystals, 8-methyl-2//-furo[2,3-/z] 
chromen-2-one (162) (0.24 g, 98%), m.p. 124-126°C (from toluene) (lit.,24 153-154°C); 
vmax(KBr)/cm-' 1614,1706 and 3317; 6H(500 MHz; CD3OD) 2.38 (3H, s, l'-CH3), 6.39 (IH, d, 
J34 9.1, 3-H), 6.78 (IH, s, 9-H), 7.40 (IH, d, J65 8.5, 6-H), 7.43 (IH, d, J5>6 8.3, 5-H) and 8.04 
(IH, d, J43 9.2,4-H); 8C(125 MHz; CD3OD) 20.1 (1*-CH3), 99.2 (C-9), 108.2 (C-6), 113.1 (C-3), 
113.8 (C-4a), 118.1 (C-9a), 123.2 (C-5), 145.8 (C-4), 147.4 (C-9b), 157.4 (C-8), 157.5 (C-6a) and 
161.9 (C-2); m/z 200 (M+, 100%) and 171 (73). 
Preparation of 8-methoxy-8-methyl-8,9-dihydro-2jy-furo[23-^]chromen-2-one (163) 
7-hydroxy-8-(2-oxopropyl)-2#-chromen-2-one (159) (0.25 g, 1.25 mmol), andp-toluenesulfonic 
acid (0.02 g) were dissolved in methanol in a two-necked flask fitted with a condenser and 
containing 4A molecular sieve. The mixture was boiled under reflux for 5 hours under an 
atmosphere of dry nitrogen, the mixture was then passed through a plug of silica gel to remove 
the catalyst, and the solvent in vacuo to afford, as white crystals, 8-methoxy-8-methyl-8,9-
dihydro-2//-furo[2,3-/i]chromen-2-one (163) (0.29 g, 100%), m.p. 121-122°C (from methanol) 
(Found: M+232.07352, CI3H1204requiresM, 232.073562); v^KBrycrn"
11615,1728 and 2941; 
5H(500 MHz; CDC13) 1.73 (3H, s, CH3), 3.20 and 3.42 (2H, 2><d, Jgem 17.1,9-CH2), 3.32 (3H, s, 
OCH3), 6.20 (IH, d, J34 9.6, 3-H), 6.75 (IH, d, J65 8.2,6-H), 7.28 (IH, d, J56 8.2,5-H) and 7.63 
(IH, d, J43 9.6,4-H); 5C(125 MHz; CDC13) 24.2 (CH3), 37.1 (9-CH2), 50.2 (OCH3), 106.8 (C-6), 
112.3 (C-3), 112.9 (C-8), 113.0 (C-4a), 114.2 (C-9a), 128.8 (C-5), 144.1 (C-4), 151.1 (C-9b), 
160.9 (C-6a) and 162.1 (C-2); m/z 232 (M+, 100%), 201 (68), 171 (52) and 115 (24). 
Preparation of methyl 2-(hydroxymethyl)acrylate (166) and dimethyl 4-oxahept-l,6-
diene-2,6-dicarboxylate (167)85 
Methyl acrylate (18.0 ml, 0.20 mol), paraformaldehyde (9.04 g, 0.30 mol) and DABCO (1.12 g, 
10 mmol) were stirred at 95°C for 4 hours in an autoclave to afford, on cooling, a mixture of the 
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product and its ether (23 g). This was used in the subsequent halogenation step without further 
purification, however separation of the two components could be achieved by column 
chromatography (30:70 ethyl acetate/hexane). Chromatography on a 2.0 g sample afforded first 
the ether, dimethyl 4-oxahept-l ,6-diene-2,6-dicarboxylate (167) as a colourless oil (1.2 g, 56%); 
vmax(thin film)/cm-
11638,1722 and 2953; 6H(500 MHz; CDC13) 3.72 (6H, s, 2xOCH3), 4.20 and 
4.26 (4H, 2xs, 2xCH2), 5.85 and 6.26 (4H, 2xm, 2xC=C//2); 8C(125 MHz; CDC13) 52.4 
(2xOCH3), 66.4 and 69.4 (2xCH2), 126.5 and 126.9 (2xC=CH2), 137.4 (2xC=CH2) and 166.7 
(2xC=0); m/z 214 (M+, <1%), 115 (100), 83 (82) and 99 (30). This was followed by methyl 2-
(hydroxymethyl)acrylate (166), also a colourless oil, (0.51 g, 44%); vmax(thin film)/cm"' 1636, 
1718 and 3422; 5H(500 MHz; CDC13) 3.76 (3H, s, OC//3), 4.31 (2H, m, CH2), 4.81 (1H, s, OH), 
5.82 and 6.28 (2H, 2xS, C=C//2); 6C(125 MHz; CDC13) 52.5 (OCH3), 62.9 (CH2), 126.4 (C=CH2), 
139.9 (OCH2) and 167.4 (C=0); m/z 116 (M
+, 6%), 87 (100), 84 (74) and 55 (58). 
Attempted preparation of methyl 2-(bromomethyl)acrylate 
A solution of methyl 2-(hydroxymethyl)acrylate (166) (10 g, 86 mmol) in cone. HBr (47% aq 
solution, 24 ml) was stirred in a two-necked round bottomed flask at 0°C. Dilute H2S04 (8% 
solution, 22 ml) was added dropwise to this solution, and the reaction mixture was then stirred 
at room temperature for a further 16 hours. The reaction mixture was then extracted with diethyl 
ether (80 ml), washed with saturated aqueous NaHC03 (3x50 ml) and with brine (50 ml). The 
organic phase was then dried (anhydrous MgS04) and the solvent removed under vacuum to 
afford a colourless oil, which, through GC-MS and NMR analysis was shown to consist only of 
starting material. 
Preparation of methyl 2-(chloromethyl)acryIate (168) 
A mixture of methyl 2-(hydroxymethyl)acrylate (166) (5.0 g, 43 mmol), DMF (0.14 ml) and dry 
benzene (2 ml) were stirred at 0°C in three-necked flask fitted with a thermometer, pressure-
equalizing addition funnel and a reflux condenser attached to an aqueous NaOH scrubber. 
Thionyl chloride (5.75 ml, 80 mmol) was added dropwise under dry nitrogen, the resulting 
mixture was then heated at 60°C for 5 hours. The reaction was then quenched via the slow 
addition of crushed ice and the mixture obtained extracted with diethyl ether. The organic layer 
was washed with brine (30 ml), dried (anhydrous MgS04), and the solvent removed in vacuo to 
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afford, as a colourless oil, methyl 2-(chloromethyl)acrylate85 (168) (3.42 g, 60%); vmax(thin 
filmVcm"1 1738, 2957 and 3459; 5H(500 MHz;CDCl3) 3.68 (3H, s, OCH3), 4.16 (2H, s, CH2), 
5.83and6.22(2H,2xS,C=CH2);6c(125MHz;CDCl3)42.1(CH2),51.9(OCH3),125.9(C=CH2), 
136.6 (OCH2) and 165.9 (C=0); m/z 134 (M
+, 14%), 103 (100), 99 (85) and 105 (34). 
Preparation of methyl 2-{[(2-oxo-2//-chromen-7-yl)oxy]methyl}acrylate (169) 
Into a 50 ml two-necked round bottomed flask fitted to a condenser, nitrogen line and pressure-
equalizing addition funnel, was placed NaH (0.312 g of a 50% oil dispersion, 6.5 mmol)t in dry 
THF (25 ml). 7-hydroxy-2#-chromen-2-one (140) (1.0 g, 6.17 mmol) in dry THF (15 ml) was 
added dropwise and the mixture allowed to stir until the evolution of hydrogen gas had ceased. 
Methyl 2-(chloromethyl)acrylate (168) (1.01 g, 7.0 mmol) was then added and the mixture boiled 
under reflux for 6 hours until TLC showed the disappearance of starting material. The solvent 
was then removed under vacuum and the residue recrystallised from methanol to afford, as pale 
yellow crystals, methyl 2-{ [(2-oxo-2//-chromen-7-yl) oxy]methyl}acrylate (169) (1.53 g, 95%), 
m.p. 95-97°C (from methanol); V^KBrycm11615,1710 and 3423; 6H(500 MHz; CDC13) 3.83 
(3H, s, C02C#3), 4.82 (1H, s, l'-CH2), 6.00 and 6.44 (2H, 2><s, 3'-CH2), 6.26 (1H, d, J34 9.4, 3-
H), 6.86 (1H, s, 8-H), 6.88 (1H, d, J65 8.5, 6-H), 7.39 (1H, d, J56 8.6, 5-H) and 7.64 (1H, d, J43 
9.4,4-H); 8C(125 MHz; CDC13) 52.4 (C02CH3), 66.8 (l'-CH2), 102.3 (C-8),113.1 (C-3), 113.2 
(C-4a), 113.7 (C-6), 127.6 (3'-CH2), 129.1 (C-5), 135.1 (C-2')5143.6 (C-4), 156.0 (C-8a), 161.4 
(C-7), 161.6 (C-2) and 165.9 (C02CH3); m/z 260 (M
+, 18%), 228 (100), 171 (51), 199 (45) and 
115(23). 
Attempted preparation of methyl 2-[(7-hydroxy-2-oxo-2//-chromen-8-yl) 
methyl] aery late (170) 
Method L-
Methyl 2-{[(2-oxo-2//-chromen-7-yl)oxy]methyl}acrylate (169) (0.40 g, 1.54 mmol) was 
dissolved in iV,JV-diethylaniline (30 ml) in a 50 ml round bottomed flask fitted with a reflux 
condenser and nitrogen line. The reaction mixture was then boiled under reflux for 10 hours after 
which time the absence of product was confirmed by 'H NMR spectroscopy. 
^ a H was washed twice with dry THF prior to use. 
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Method 2.-
Methyl 2-{[(2-oxo-2//-chromen-7-yl)oxy]methyl}acrylate (169) (0.40 g, 1.54 mmol) was 
dissolved in a suspension of JV.jV-diethylaniline (30 ml) containing aluminium chloride (0.10 g, 
0.75 mmol) in a 50 ml round bottomed flask fitted with a reflux condenser and nitrogen line. The 
reaction mixture was then boiled under reflux, and analysis of the reaction mixture after 4, 8 and 
12 hours revealed that no product had formed. 
Method 3.-
Methyl 2-{[(2-oxo-2#-criromen-7-yl)oxy]methyl}acrylate (169) (0.40 g, 1.54 mmol) was 
dissolved in trifluoroacetic acid (40 ml) in a 100 ml round bottomed flask. The reaction mixture 
was then boiled under reflux for 24 hours, after which time the absence of any product was 
confirmed by GC-MS and NMR spectroscopy. 
Method 4.-
Methyl 2-{[(2-oxo-2/f-chromen-7-yl)oxy]methyl}acrylate (169) (0.30 g, 1.15 mmol) was 
dissolved in toluene containing/?-toluenesulfonic acid (0.05 g) as a catalyst. The reaction mixture 
was then boiled under reflux, and analysis after 8,12 and 16 hours revealed the absence of any 
desired product. 
3.2.2 Synthetic work towards sulfur analogues 
Preparation of 0-(8-allyl-2-oxo-2H-chromen-7-yl)Ar^V-dimethylcarbamotliioate(176) 
8-allyl-7-hydroxy-2//-chromen-2-one (142) (2.0 g, 9.9 mmol) was dissolved in dry DMF (20 ml) 
in a two-necked flask fitted with a thermometer, reflux condenser and nitrogen line. NaH (0.53 
g of a 50% oil dispersion, 11.0 mmol)1 was then added. Once the evolution of hydrogen gas had 
ceased, dimethylthiocarbamoyl chloride (1.29 g, 10.5 mmol) was added and the reaction mixture 
was heated at 60°C for 30 minutes. The reaction mixture was then poured into 50 ml of cold 
water and the precipitate obtained was filtered, dried, and recrystallised from ethanol to afford, 
as cream crystals, ^-(S-allyl^-oxo^F-criromen^-yOA^A^-dimethylcarbamothioate (176) (2.71 
^ a H was washed twice with dry THF prior to use. 
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g, 96%), m.p. 103-104°C (from ethanol) (Found: M+ 289.07775, C15H1503SN requires M, 
289.07727); V^KBrVcm1 1595, 1671, 1723 and 2925; 6H(500 MHz; CDC13) 3.38 and 3.47 
[6H, 2xs, N(C#3)2], 3.54 (2H, d, Jv>r 6.3, l'-CH2), 5.03 (1H, dd, JC1S10 and Jgem 1.5, C=CH) and 
5.08 (1H, dd,Jtrans 17.1 and Jgem 1.6, C=CH), 5.95 (lH,ddt, Jtrans 17.1, JC1S 10.0 and J2,r6.3,2'-H), 
6.40 (1H, d, J3A 9.6, 3-H), 7.03 (1H, d, J65 8.4, 6-H), 7.38 (1H, d, J56 8.4 5-H) and 7.69 (1H, d, 
J43 9.6,4-H); 6C(125 MHz; CDC13) 28.7 (C-l'), 39.5 and44.1 [N(CH3)2], 116.5 (C-3), 116.8 (C-
3'), 117.5 (C-4a), 121.1 (C-6), 122.4 (C-8), 126.5 (C-5), 135.1 (C-2'), 144.1 (C-4), 153.5 (C-8a), 
155.4 (C-7), 161.2 (C-2) and 187.1 (C=S); m/z 289 (M+, 24%) and 217 (100). 
Preparation of5-(8-allyl-2-oxo-2fi-chromen-7-yl)AyV-dimethylcarbamothioate(177) 
<9-(8-allyl-2-oxo-2//-chromen-7-yl)A/; N-dimethylcarbamothioate (176) (2.70 g, 9.34 mmol) was 
heated neat under nitrogen in a two-necked flask containing a thermometer at ca. 230°C for 40 
minutes, cooled, and the residue recrystallised from ethanol to afford the rearranged product, S-
(8-allyl-2-oxo-2/f-chromen-7-yl)7V;^-dimethylcarbamothioate (177) (2.32 g, 86%), m.p. 101-
105°C (from ethanol) (Found: M+ 289.07765, C15H1503SN requires M, 289.07727); 
vmax(KBr)/cm-' 1543,1603 and 1723; 6H(500 MHz; CDC13) 3.02 and 3.14 [6H, 2*s, N(C#3)2], 
3.81 (2H,d, Jvy 6.2, l'-CH2),5.01-5.04(2H,m,3'-CH2),5.97(1H,ddt, Jtrans 17.6, Jcis9.8andJTV 
6.2, 2'-H), 6.44 (1H, d, J34 9.6, 3-H), 7.36 (1H, d, J65 8.2, 6-H), 7.46 (1H, d, J56 8.0, 5-H) and 
7.69 (1H, d, J4>3 9.6,4-H); 6C(125 MHz; CDC13) 32.1 (l'-CH2), 37.3 [N(CH3)2], 116.5 (3'-CH2), 
117.5 (C-3), 119.8 (C-4a), 125.8 (C-6), 132.8 (C-8), 133.4 (C-5), 133.5 (C-7), 135.1 (C-21), 143.6 
(C-4), 152.3 (C-8a), 160.6 (C-l) and 165.7 [NC(0)S]; m/z 289 (M+, 30%) and 217 (100). 
Preparation of S- [8-(2,2-dimethoxyethyI)-2-oxo-2//-chromen-7-yl]./V,iV-diinethyl 
carbamothioate (182) 
5-(8-allyl-2 -oxo-2//-chromen-7-yl)^,A^-dimethylcarbamothioate (177) (1.0 g, 3.46 mmol), was 
dissolved in dry THF in a three-necked round bottomed flask connected to an ozonator and two 
traps containing acidified KI (1.1 M solution). The reaction flask was cooled to -78°C using a 
solid C02/acetone slurry and ozone was bubbled through the mixture for ca. 80 minutes until 
analysis by TLC showed the disappearance of starting material. Dimethyl sulfide (0.3 ml, 4.15 
mmol) was then added and the mixture stirred at -10°C for a further 3 hours while allowing the 
temperature to warm to room temperature. Methanol (20 ml),p-toluenesulfonic acid (0.02 g) and 
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4A molecular sieve {ca. 0.5 g) were then added and the reaction mixture boiled under reflux for 
4 hours until TLC showed there was no starting material left. The volatile components were 
removed in vacuo and the final product purified via radial chromatography (50:50 ethyl 
acetate/hexane) to afford S- [8-(2,2-dimethoxyethyl)-2-oxo-2//-chromen-7-yl]Ar, TV-dimethyl 
carbamothioate (182) (0.99 g, 84%), m.p. 96-99°C (from methanol) (Found: M+ 337.09877, 
C16H1905SN requires M, 337.09839); vmax(KBr)/cm-' 1654, 1727 and 2948; 6H(500 MHz; 
CDC13) 3.00 and 3.12 [6H, 2xS, N(C#3)2], 3.34 (6H, s, 2xOC//3), 3.40 (2H, d, J,.2,5.7, l'-CH2), 
4.69 (IH, t, J2A. 5.7,2'-H), 6.43 (IH, d, J3A 9.4, 3-H), 7.35 (IH, d, J65 8.2,6-H), 7.45 (IH, d, J56 
8.2, 5-H) and 7.68 (IH, d, J43 9.6, 4-H); 6C(125 MHz; CDC13) 31.9 (1*-CH2), 36.9 [N(CH3)2], 
53.9(2xOCH3), 104 (C-2'), 117 (C-3), 119.2 (C-4a), 125.6 (C-6), 129.8 (C-8), 133.2 (C-5), 134.5 
(C-7), 143.3 (C-4), 152.3 (C-8a), 160.1 (C-2) and 165.5 [NC(O)S];w/z337(M+,28%),203(100) 
and 234 (28). 
Preparation of 8-methoxy-8,9-dihydro-2/T-thieno[2,3-/i]chromen-2-one (185) 
5-[8-(2,2-dimethoxye%l)-2-oxo-2//-chromen-7-yl]Ar,J/V-dimethylcarbamothioate (182) (0.80 g, 
2.3 mmol) was added to a stirred mixture of dry methanol containing KOH (0.168 g, 3.0 mmol) 
in a round bottomed flask fitted with a condenser and heated under reflux for ca. 4 hours. The 
reaction mixture was then acidified (HCl) and boiled under reflux for a further 2 hours. Water 
(5 ml) was then added and the product extracted with ether (3*30 ml). The organic layer was 
dried (anhydrous MgS04) and the solvent removed in vacuo to yield, as an orange oil from which 
the product crystallised out as orange crystals, 8-methoxy-8,9-dihydro-2//-thieno[2,3-/z]chromen-
2-one (185) (0.156 g, 29%), m.p. 141-143°C (from methanol) (Found: M+234.03381, C12HI0O3S 
requires M, 234.03507); v^KBrycm'1 1600,1717 and 3452; 8H(500 MHz; CDC13) 3.38 (3H, 
s, CH3), 3.51 (IH, dd, Jgem 17.3, J9a,8 5.5,9-CHJ and 3.78 (IH, d, Jgem 17.3,9-CHb), 5.54 (IH, d, 
J89a 5.5,8-H), 6.30 (IH, d,y349.6,3-H), 7.18 (IH, d, J65 8.0,6-H), 7.29 (IH, d, J56 8.0,5-H) and 
7.66 (IH, d, J43 9.6,4-H); 6C(125 MHz; CDC13) 40.1 (9-CH2), 56.3 (l'-CH3), 92.7 (C-8), 114.5 
(C-3), 115.9 (C-9a), 118.8 (C-6), 125.3 (C-4a), 127.6 (C-5), 143.6 (C-4), 145.7 (C-6a), 150.6 (C-
9b) and 160.6 (C-2); m/z 234 (M+, 92%), 203 (100), 147 (60) and 174 (21). 
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Attempted preparation of 8-ethoxy-8,9-dihydro-2//-thieno[2,3-/»]chromen-2-one 
(186) 
5'-[8-(2,2-dimethoxyethyl)-2-oxo-2//-chromen-7-yl]MiV-dimethylcarbamothioate (182) (0.80 g, 
2.3 mmol) was added to a mixture of dry ethanol containing KOH (0.168 g, 3.0 mmol) and heated 
under reflux for ca. 4 hours. The reaction mixture was then acidified (HC1) and boiled under 
reflux for a further 2 hours. Water (5 ml) was then added and the product extracted with ether 
(3><30 ml). The organic layer was dried (anhydrous MgS04) and removed in vacuo to yield an 
orange oil. GC-MS and NMR spectroscopic analysis of this oil could neither confirm nor 
disprove the presence of the desired product. 'H NMR spectroscopy proved inconclusive due to 
the presence of impurities, only the aromatic proton signals could be observed with any clarity, 
and attempts to purify the oil using chromatography were unsuccessful, with 'H NMR 
spectroscopic analysis of the bands being similar to that of the original sample. GC-MS analysis 
did provide evidence for the presence of the hemiacetal (184), and high resolution mass 
spectrometry analysis the presence of the charged species 187 (possibly formed from the 
hemiacetal losing water to form a positively charged sulfur atom, see scheme 53, page 66) 
providing further evidence for the presence of the hemiacetal in the original reaction mixture. 
3.2.3 Synthetic work towards selenium analogues 
Attempted Preparation of 8-allyl-7-bromo-2/f-chromen-2-one (188) 
Method 1.-
8-allyl-7-hydroxy-2/f-chromen-2-one (142) (0.50 g, 2.47 mmol) and triphenylphosphine 
dibromide (1.10 g, 2.60 mmol) were dissolved in dry DMF (30 ml) in a 50 ml two-necked round 
bottomed flask fitted with a reflux condenser and a nitrogen line. The reaction mixture was boiled 
under reflux for 3 hours, where the absence of any formation of product was confirmed by TLC 
and GC-MS analysis. The reaction mixture was then boiled under reflux for a further 4 hours, and 




Preparation of 8-allyl-2-oxo-2//-chromen-7-yl trifluoromethanesulfonate (197) 
8-allyl-7-hydroxy-2//-chromen-2-one (142) (0.50 g, 2.47 mmol) was dissolved in dry THF (15 
ml) in a 25 ml two-necked round bottomed flask fitted with a nitrogen line. The reaction mixture 
was cooled to -70°C and freshly distilled triethylamine (1.08 ml, 7.72 mmol) was added via a 
cannula, followed by trifiic anhydride (0.50 ml, 2.97 mmol). The mixture was stirred for 15 
minutes after which the organic solvents were removed under vacuum. Water (10 ml) was added, 
and the product extracted with ether (2*20 ml) and dried (anhydrous MgS04). Removal of the 
solvent afforded, as a pale yellow oil, 8-allyl-2-oxo-2//-chromen-7-yl trifluoromethanesulfonate 
(197)(0.78g,94%); vmax(KBr)/cm-' 1421,1601,1743 and 3431;6H(500 MHz; CDC13) 3.65 (2H, 
d, JV2. 5.9, l'-CH2), 4.93 (IH, dd, ycis 10.0 and Jgem 1.8, C=CH) and 5.21 (IH, dd, Jtrans 16.9 and 
7gem 1.8, C=CH), 5.94 (IH, ddt, Jttans 16.9, JC1S 10.0 and./,.,. 5.9,2'-H), 6.45 (IH, d, J3>49.1,3-H), 
7.22 (IH, d, J65 8.3,6-H), 7.45 (IH, d„/56 8.5,5-H) and 7.70 (IH, d,J43 9.3,4-H); 6C(125 MHz; 
CDC13)28.1 (l'-CH2), 117.6 (3'-CH2,C-3 and C-6), 118.6 (q,JCF 320, CF3), 118.8 (C-4a), 122.4 
(C-8), 127.2 (C-5), 132.9 (C-2'), 142.9 (C-4), 149.5 (C-7), 153.2 (C-8a), 159.6 (C-2); m/z 334 
(M+, 44%), 173 (100), 201 (76) and 128 (41). 
Part B: 
Attempted Preparation of 8-allyl-7-bromo-2Jy-chromen-2-one (188) 
8-allyl-2-oxo-2//-chromen-7-yl trifluoromethanesulfonate (197) (0.40 g, 1.24 mmol) was 
dissolved in acetonitrile (30 ml) in a 50 ml round bottomed flask fitted with a reflux condenser 
attached to a nitrogen line. Tetrabutylammonium bromide (0.46 g, 1.44 mmol) was then added, 
and the reaction mixture boiled under reflux for 16 hours. Analysis of the sample using GC-MS 
and 13C NMR spectroscopy confirmed the absence of any product. 
Preparation of l-(aHyloxy)-3-bromobenzene (199) 
K2C03(5.59 g, 40.5 mmol) was added to a solution of 3-bromophenol (198) (5.00 g, 28.9 mmol) 
in acetone (120 ml) contained in a 250 ml two-necked flask fitted with a reflux condenser and 
a nitrogen line. 3-bromo-l-propene (5.50 ml, 63.5 mmol) was then added and the reaction 
mixture boiled under reflux for 5 hours, after which the K2C03 was filtered off using a scintered 
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glass filter funnel. The filtrate and washings were then reduced in vacuo to leave a brown oil, 1-
(allyloxy)-3-bromobenzene (199) (6.08 g, 98%); vmax(thin filmVcm
1 1474, 1590 and 3426; 
6H(500 MHz; CDC13) 4.52 (2H, d, J,,2, 5.3, l'-CH2), 5.32 (1H, dd, JC1S 10.5 and Jgem 1.4, C=CH) 
and 5.43 (1H, dd, Jtrans 17.2 and Jgem 1.4, C=CH), 6.04 (1H, ddt, J^ 17.1, JC1S 10.5 and J2.,, 5.4, 
2'-H), 6.85 (1H, d, J65 8.0, 6-H) and 7.08-7.16 (3H, m, Ar-H); 6C(125 MHz; CDC13) 68.8 (1'-
CH2), 113.7 (C-6), 117.8 (3'-CH2), 117.9 (C-2), 122.7 (C-3), 123.9 (C-4), 130.5 (C-5), 132.6 (C-
2') and 159.3 (C-l); m/z 214 [M+(81Br), 73%], 105 (100), 133 (89), 145 (30), 174 (22) and 199 
(22). 
Preparation of 2-allyl-3-bromophenol (200a) and 2-allyl-5-bromophenol (200b) 
l-(allyloxy)-3-bromobenzene (199) (6.08 g, 28.5 mmol) was heated neat under nitrogen to ca. 
200°C for 4 hours until analysis by TLC showed that the starting product had disappeared. The 
two possible regioisomers for the rearrangement reaction were then separated using column 
chromatography (5:95 ethyl acetate/hexane as eluant) on some of the reaction mixture (1.0 g, 4.69 
mmol). This afforded first, as an orange oil, 2-allyl-5-bromophenol (200b) (0.41 g, 41%); 
vmax(thin filmycm-
1 1408,1495,1589 and 3444; 6H(500 MHz; CDCLJ 3.36 (2H, d, J,,2,6.4,1'-
CH2), 5.15 (2H, m, 3'-CH2), 5.37 (1H, br. s, OH), 5.98 (1H, ddt, Jtrans 17.1, Jcjs 10.3 and J2,r 6.4, 
2'-H) and 6.99 (3H, m, Ar-H); 6C(125 MHz; CDC13) 34.9 (1*-CH2), 117.1 (3'-CH2), 118.9 (C-2), 
120.8 (C-3), 122.2 (C-4), 122.8 (C-6), 131.9 (C-5), 135.7 (C-2') and 155.2 (C-l); m/z 214 
[M+(81Br), 100%], 105 (81), 133 (76), 174 (33) and 145 (23). The second fraction to be eluted, 
also an orange oil, was 2-allyl-3-bromophenol (200a) (0.53 g, 53%); Vmax(thin filmycm"
1 1446, 
1579 and 3448; 6H(500 MHz; CDC13) 3.61 (2H, d, JV2. 5.9, l'-CH2), 5.08 (3H, m, 3'-CH2 and -
OH), 5.96 (1H, ddt, J^ 16.9, Jcis 10.3 and J2,,. 5.9, 2'-H), 6.73 (1H, d, J65 8.0, 6-H), 6.94 (1H, 
t, 75>6 8.0and J5A 8.0, 5-H) and 7.14 (1H, d, J4S 8.0, 4-H); 8C(125 MHz; CDC13) 34.3 (l'-CH2), 
114.9 (C-6), 116.2 (3'-CH2), 125.3 (C-4), 125.6 (C-3), 125.7 (C-2), 128.4 (C-5), 134.5 (C-2') and 
154.8 (C-l); m/z 214 [M+(81Br), 65%], 105 (100), 133 (89) and 187 (14). 
EXPERIMENTAL 101 
Attempted preparation of 8-allyl-7-bromo-4-methyl-2H-chromen-2-one (201) 
Method L-
Concentrated sulfuric acid (0.71 ml) was added to a two-necked round bottomed flask, fitted with 
a pressure-equalizing dropping funnel and nitrogen line, and cooled to 5°C using an ice bath. A 
mixture of 2-allyl-3-bromophenol (200a) (0.20 g, 0.94 mmol) and ethyl acetoacetate (0.12 ml, 
0.94 mmol) was then added dropwise, ensuring the temperature did not rise above 10°C. When 
the addition was complete, the mixture was warmed to room temperature, and stirred overnight. 
Ice water (10 ml) was then added to the solution, and the precipitate was filtered off under 
vacuum and washed with water. Analysis by GC-MS and NMR spectroscopy revealed the 
absence of the formation of any product. 
Method 2.-
In a two-necked round bottomed flask fitted with a pressure-equalizing dropping funnel and a 
nitrogen line, 2-allyl-3-bromophenol (200a) (0.20 g, 0.94 mmol) and ethyl acetoacetate (0.12 ml, 
0.94 mmol) were dissolved in dry nitrobenzene. A mixture of anhydrous aluminium chloride 
(0.25 g, 1.88 mmol) in hot dry nitrobenzene (10 ml) was added, and the mixture heated at 125-
130°C for 2 hours under nitrogen. The mixture was then cooled, and ice and concentrated HC1 
(0.1 ml) was added. A small aliquot was removed, the nitrobenzene removed under high 
vacuum, and a GC-MS and NMR sample prepared. The sample was found to consist only of 
starting material, with no desired product evident. 
Method 3.-
Hypophosphoric acid (2 ml) was added to a two-necked round bottomed flask, fitted with a 
pressure-equalizing dropping funnel and nitrogen line and cooled to 5°C using an ice bath. A 
mixture of 2-allyl-3-bromophenol (200a) (0.20 g, 0.94 mmol) and ethyl acetoacetate (0.12 ml, 
0.94 mmol) was then added dropwise, after which the reaction mixture was heated at 80°C for 




2-allyl-3-bromophenol (200a) (1.0 g, 4.69 mmol) was dissolved in THF (30 ml) in atwo-necked 
round bottomed flask fitted with a nitrogen line. NaHC03 (0.39 g, 4.69 mmol) was then added 
and the mixture stirred for 10 minutes. Ethyl malonyl chloride (0.721 ml, 5.6 mmol) was then 
added using a cannula and the mixture was stirred overnight. Analysis using GC-MS and NMR 
spectroscopy showed that no desired product had formed, with only starting material being 
present in the reaction mixture. 
Attempted preparation of 8-allyl-7-bromo-4-hydroxy-2//-chromen-2-one (203) 
THF (10 ml) was added to a two-necked flask fitted with a nitrogen line. 2-allyl-3 -bromophenol 
(200a) (0.13 g, 0.61 mmol), malonic acid (0.07 g, 0.67 mmol), anhydrous zinc chloride (0.25 g, 
1.83 mmol) and phosphorus oxychloride (0.17 ml, 1.83 mmol) were then added and the mixture 
was boiled under reflux for a total of 40 hours. Analysis by GC-MS and NMR spectroscopy 
revealed only the presence of starting material, with no evidence of the desired product. 
Preparation of 2-allyl-3-bromophenyl terf-butyl(dimethyl)silyl ether (204) 
Method 1.-
2-allyl-3-bromophenol (200a) (1.0 g, 4.69 mmol) was dissolved in THF (20 ml) in a two-necked 
flask fitted with a nitrogen line. Tert-butyl dimethylsilyl chloride (0.86 g, 5.7 mmol) and 
imidazole (0.80 g, 11.7 mmol) were added to the flask and the reaction mixture stirred overnight. 
Analysis by GC-MS and NMR spectroscopy revealed that no reaction had occurred, and only the 
starting material was present. 
Method 2.-
NaH (0.15 g of a 50% oil dispersion, 3.1 mmol)§ was added to dry THF (20 ml) in a 50 ml two-
necked flask under nitrogen. 2-allyl-3-bromophenol (200a) (0.5 g, 2.34 mmol) was then added 
and the reaction mixture was stirred until the evolution of hydrogen gas had ceased (ca. 30 min). 
fert-Butyl dimethylsilyl chloride (0.42 g, 2.8 mmol) was added and the mixture stirred overnight 
under an atmosphere of dry nitrogen. The reaction mixture was then diluted with ether (20 ml), 
§NaH was washed twice with dry THF prior to use. 
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washed with aq. 10% NaHC03 solution (20 ml) and then with brine solution (15 ml). The organic 
layer was separated, dried (anhydrous MgS04) and the solvent removed under vacuum to afford, 
as a yellow oil, 2-allyl-3-bromophenyl ter/-butyl(dimethyl)silyl ether (204) (0.73 g, 95%); 
vmax(thin filmycm-
11273, 1456, 2930 and 2957; 6H(500 MHz; CDC13) 0.25 [6H, s, Si(C#3)2], 
1.02 [9H, s, C(C#3)3], 3.57 (2H, d, J,,2, 6.3, l'-CH2), 5.01 (2H, m, 3'-CH2), 5.92 (1H, ddt, Jtrans 
17.4, Jcis 10.1 and J2,r 6.4,2'-H), 6.76 (1H, d, J65 8.0,6-H), 6.95 (1H, t, J56 8.0 and J54 8.1, 5-H) 
and 7.16 (1H, d, J4>5 8.1, 4-H); 6C(125 MHz; CDC13) -4.2 [Si(CH3)2], 18.2 [C(CH3)3], 25.7 
[C(CH3)3], 34.2 (l'-CH2), 115.3 (3'-CH2), 117.3 (C-6), 125.4 (C-4), 125.8 (C-3), 127.7 (C-5), 
130.5 (C-2), 134.9 (C-2') and 154.5 (C-l); m/z 328 [M+(81Br), 5%] 271 (100), 243 (78), 175 (43), 
190 (41) and 229 (26). 
Preparation of [3-bromo-2-(2,2-dimethoxyethyl)phenoxy](terf-butyl)dimethylsilane 
(205) 
2-allyl-3-bromophenyl tert-butyl(dimethyl)silyl ether (204) (0.70 g, 2.14 mmol) was dissolved 
in THF (50 ml) in a three-necked round bottomed flask connected to an ozonator and two traps 
containing acidified KI (1.1 M solution). The reaction flask was cooled to -78°C using a solid 
C02/acetone slurry and ozone was bubbled through the mixture for ca. 80 minutes until analysis 
by TLC showed the disappearance of starting material. Dimethyl sulfide (0.19 ml, 2.60 mmol) 
was added and the mixture stirred at -10°C for a further 3 hours while allowing the temperature 
to warm to room temperature. Half the THF (ca. 25 ml) was then removed under vacuum, and 
methanol (20 ml) and/?-toluenesulfonic acid (0.05 g) added, as well as 3 A molecular sieve (0.5 
g). The mixture was then boiled under reflux for 3 hours. Removal of the solvent under vacuum, 
and the catalyst by passage through a plug of silica gel, afforded, as a yellow oil, [3-bromo-2-
(2,2-dimethoxyethyl)phenoxy](rerr-butyl) dimethylsilane (205) (0.67 g, 84%); vmax(thin film)/cm" 
11451,1588,2930 and 2955; 5H(500 MHz; CDC13) 0.23 [6H, s, Si(C//3)2], 0.98 [9H, s, C(C//3)3], 
3.13 (2H, d, J,,2,5.7, T-CH2), 3.47 (6H, s, 2><OCH3), 4.72 (1H, t, JTV 5.7,2'-H), 6.80 (1H, d, J65 
8.0, 6-H), 6.93 (1H, t, J5>6 8.0 and J54 8.2, 5-H) and 7.18 (1H, d, J45 8.2, 4-H); 8C(125 MHz; 
CDC13)-4.1 [Si(CH3)2], 18.3 [C(CH3)3],25.9 [C(CH3)3], 34.6(l'-CH2), 53.8(2*OCH3), 104.2(C-
2'), 117.8 (C-6), 124.9 (C-3), 125.8 (C-4), 126.3 (C-2), 128.7 (C-5) and 155.3 (C-l); m/z 376 
[M+(81Br), 3%], 214 (100), 118 (24) and 199 (21). 
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Attempted preparation of ferf-butyl[2-(2,2-dimethoxyethyl)-3-(methylseIenyl) 
phenoxy]dimethylsilane (206) 
[3-bromo-2-(2,2-dimethoxyethyl)phenoxy](rerr-butyl)dimethylsilane (205) (0.60 g, 1.60 mmol) 
and K2C03 (0.25 g, 1.70 mmol) were suspended in acetonitrile (7 ml) in a 20 ml round bottomed 
flask fitted to a nitrogen line. The slurry was then cooled to -5°C using a salt/ice bath and 
methaneselenol (162 ul, 1.70 mmol) was added. The mixture was then stirred at 25°C for 24 
hours and then poured onto water (10 ml). The organic layer was extracted with ether, dried with 
MgS04, and evaporated to dryness under vacuum. Analysis of the brown oil remaining confirmed 
the absence of the desired product, but from GC-MS evidence, and the disappearance of the tert-
butyl dimethylsilyl peaks in the 'H NMR spectrum, it was concluded that this protecting group 
was cleaved off during the reaction period. 
Attempted preparation of 2-allyl-3-(methylselenyl)phenol (207) 
Method 1.-
2-allyl-3-bromophenol (200a) (0.4 g, 1.88 mmol) and K2C03 (0.28 g, 2.02 mmol) were 
suspended in acetonitrile (10 ml) in a 50 ml round bottomed flask fitted with a nitrogen line. The 
slurry was cooled to -5°C using a salt/ice bath, methaneselenol (200 ul, 2.10 mmol) was added, 
and the mixture stirred at 25°C for 24 hours, after which it was poured onto water (10 ml). 
Analysis of the organic phase established the absence of any reaction. 
Method 2.-
Powdered selenium metal (0.176 g, 2.23 mmol) was suspended in dry THF (5 ml) in a 20 ml two-
necked flask fitted with a nitrogen line. Methyllithium (1.53 ml of a 1.6 M commercial solution, 
2.44 mmol) was then added dropwise via a syringe to the stirred suspension at room temperature. 
After ca. 20 min all the grey selenium had disappeared and a white suspension was obtained. A 
solution of 2-allyl-3-bromophenol (200a) (0.30 g, 1.40 mmol) in dry DMF (10 ml) was then 
added to this suspension. The flask was then heated so as to allow the THF and ether to distill off 
under nitrogen. The reaction mixture was then stirred at 120°C for a total of 36 hours. Analysis 
of the reaction mixture after this time by GC-MS and NMR spectroscopy revealed the absence 
of any reaction. 
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5. APPENDIX 
CRYSTALLOGRAPHIC DATA FOR 8-METHOXY-8,9-DIHYDRO-2#-FURO[2,3-/i] 
CHROMEN-2-ONE (150a). 







Crystal system, space group 
Unit cell dimensions 
Volume 




Theta range for data collection 
Index ranges 
Reflections collected / unique 
Completeness to 2theta = 27.96 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 







a = 7.902(3) A alpha = 90.031(19) deg. 
b - 7.2686(14) A beta = 99.44(3) deg. 
c = 17.500(5) A gamma = 90.00(3) deg. 
991.6(5) A3 




2.36 to 27.96 deg. 
-10<=h<=10, -3<=k<=9, -4<=1<=23 
3555/2339 [R(int) = 0.0221] 
97.9% 
0.9729 and 0.8605 
Full-matrix least-squares on F2 
2339/0/152 
1.209 
Rl=0.0812,wR2 = 0.3114 
R l = 0.0931, wR2 = 0.3211 
0.594 and-0.419 e.A"3 
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Table 3. Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(A2 x 103) for 8-methoxy-8,9-dihydro-2/^furo[2,3-/j]chromen-2-one (150a).1 U(eq) 


















































































*For atom numbering see Figure 5, page 43. 
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Table 5. Anisotropic displacement parameters (A2 x 103)for 8-methoxy-8,9-dihydro-27/-
furo[2,3-^]chromen-2-one (150a). The anisotropic displacement factor exponent 
takes the form: -2 pi2 [ h2 a*2 Ul 1 + ... + 2 h k a* b* U12 ] 


















































































































Table 6. Hydrogen coordinates (x 104) and isotropic 
displacement parameters (A2 x 103) for 8-methoxy-8,9-dihydro-2//-furo[2,3-/i] 
chromen-2-one (150a). 




















































Table 7. Torsion angles [deg] for 8-methoxy-8,9-dihydro-2//-furo[2,3-/z]chromen-2-
one (150a). 
C(5)-0(2)-C(l)-0(l) 
C(5)-0(2)-C(l)-C(2) 
0(1)-C(1)-C(2)-C(3) 
0(2)-C(l)-C(2)-C(3) 
C(l)-C(2)-C(3)-C(4) 
C(2)-C(3)-C(4)-C(9) 
C(2)-C(3)-C(4)-C(5) 
C(l)-0(2)-C(5)-C(6) 
C(l)-0(2)-C(5)-C(4) 
C(9)-C(4)-C(5)-0(2) 
C(3)-C(4)-C(5)-0(2) 
C(9)-C(4)-C(5)-C(6) 
C(3)-C(4)-C(5)-C(6) 
0(2)-C(5)-C(6)-C(7) 
C(4)-C(5)-C(6)-C(7) 
O(2)-C(5)-C(6)-C(10) 
C(4)-C(5)-C(6)-C(10) 
C(ll)-0(3)-C(7)-C(6) 
C(ll)-0(3)-C(7)-C(8) 
C(5)-C(6)-C(7)-0(3) 
C(10)-C(6)-C(7)-O(3) 
C(5)-C(6)-C(7)-C(8) 
C(10)-C(6)-C(7)-C(8) 
0(3)-C(7)-C(8)-C(9) 
C(6)-C(7)-C(8)-C(9) 
C(7)-C(8)-C(9)-C(4) 
C(5)-C(4)-C(9)-C(8) 
C(3)-C(4)-C(9)-C(8) 
C(5)-C(6)-C(10)-C(ll) 
C(7)-C(6)-C(10)-C(ll) 
C(12)-0(4)-C(ll)-0(3) 
C(12)-O(4)-C(ll)-C(10) 
C(7)-0(3)-C(ll)-0(4) 
C(7)-O(3)-C(ll)-C(10) 
C(6)-C(10)-C(ll)-O(4) 
C(6)-C(10)-C(ll)-O(3) 
-180.0(3) 
-0.4(5) 
179.9(4) 
0.4(6) 
0.4(6) 
178.6(4) 
-1.1(5) 
-179.4(3) 
-0.3(5) 
-178.6(3) 
1.1(5) 
0.4(5) 
-179.9(3) 
178.8(3) 
-0.2(5) 
-1.0(5) 
180.0(3) 
-6.2(4) 
174.6(3) 
-179.4(3) 
0.4(4) 
-0.2(5) 
179.6(3) 
179.6(3) 
0.5(6) 
-0.3(6) 
-0.1(5) 
-179.8(3) 
-175.1(3) 
5.1(3) 
-69.7(3) 
172.4(3) 
-109.7(3) 
9.2(3) 
111.1(3) 
-8.6(3) 
